<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="ebj" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">ebj</book-part-id>
      <title-group>
        <title>Junctional Epidermolysis Bullosa</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pfendner</surname>
            <given-names>Ellen G</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Director, EBDx Program<break/>GeneDx, Inc<break/>Gaithersburg, Maryland</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lucky</surname>
            <given-names>Anne W</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Director, Cincinnati Children's Epidermolysis Bullosa Center <break/>Cincinnati Children's Hospital <break/>Cincinnati, Ohio</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2008-02-22" date-type="created">
          <day>22</day>
          <month>2</month>
          <year>2008</year>
        </date>
        <date iso-8601-date="2014-01-02" date-type="updated">
          <day>2</day>
          <month>1</month>
          <year>2014</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="joubert" document-type="chapter">Joubert Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="jh" document-type="chapter">Juvenile Hereditary Hemochromatosis</related-object>
      <abstract id="ebj.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes Herlitz JEB (aka lethal) and non-Herlitz JEB (aka non-lethal). In Herlitz JEB, the classic severe form of JEB, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In non-Herlitz JEB, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Because the clinical features of all types of EB overlap significantly, examination of a skin biopsy by transmission electron microscopy (TEM) and/ or immunofluorescent antibody/antigen mapping is usually required to establish the diagnosis of JEB, especially in infants. The four genes in which pathogenic variants are known to cause JEB are <italic toggle="yes">LAMB3</italic> (70% of all JEB), <italic toggle="yes">COL17A1</italic> (12%), <italic toggle="yes">LAMC2</italic> (9%), and <italic toggle="yes">LAMA3</italic> (9%).</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Lance and drain new blisters and dress with three layers (primary: non-adherent; secondary: for stability and protection; third: elastic properties to ensure integrity). Protect skin from shearing forces; teach caretakers proper handling of infants and children; treatment of granulation tissue with high-potency topical steroids, silver nitrate, electrocautery, or autologous skin grafts; dilation of esophageal strictures; standard treatment of gastroesophageal disease; tracheostomy if appropriate; regular dental care; appropriate footwear and physical therapy to promote/preserve ambulation; psychosocial support, including social services and psychological counseling; appropriate management of chronic pain; treatment of urologic and renal disease using standard treatments.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Antiseptics to treat wound infections; attention to fluid and electrolyte balance in severely affected infants; additional nutritional support including feeding gastrostomy when necessary; calcium, vitamin D, zinc, and iron supplements.</p>
          <p><italic toggle="yes">Surveillance:</italic> Routine screening for iron-deficiency anemia, zinc deficiency, osteopenia and/or osteoporosis; periodic echocardiograms to evaluate for dilated cardiomyopathy; in the second decade of life, surveillance for squamous cell carcinoma is appropriate.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Ordinary medical tape or Band-Aids<sup>&#x000ae;</sup>, poorly fitting or coarse-textured clothing and footwear, activities that in general traumatize the skin (e.g., hiking, mountain biking, contact sports).</p>
          <p><italic toggle="yes">Other:</italic> Consider cesarean section delivery to reduce trauma to the skin of an affected fetus.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>JEB is inherited in an autosomal recessive manner. The parents of an affected child are usually obligate heterozygotes (i.e., carriers). Because germline mosaicism and uniparental isodisomy have been reported, carrier status of parents needs to be confirmed with molecular genetic testing. At conception, each sib of an affected individual whose parents are both carriers has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. The offspring of an individual with autosomal recessive JEB are obligate heterozygotes (carriers) for a pathogenic variant. Carrier testing for family members at increased risk and prenatal diagnosis for pregnancies at increased risk are possible if both pathogenic variants have been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="ebj.Diagnosis">
        <title>Diagnosis</title>
        <sec id="ebj.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of junctional epidermolysis bullosa (JEB) is suspected in individuals with fragility of the skin with:</p>
          <list list-type="bullet">
            <list-item>
              <p>Blistering with little or no trauma. Blistering may be mild or severe; however, blisters generally heal with no significant scarring.</p>
            </list-item>
            <list-item>
              <p>Significant oral and mucous membrane involvement</p>
            </list-item>
          </list>
          <p>Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally in and around the upper airway and the trachea. (See <xref ref-type="fig" rid="ebj.F1">Figure 1</xref>, <xref ref-type="fig" rid="ebj.F2">Figure 2</xref>.)</p>
          <p>Because the clinical features of all types of epidermolysis bullosa (EB) overlap significantly (see <xref ref-type="sec" rid="ebj.Differential_Diagnosis">Differential Diagnosis</xref>), clinical diagnosis is unreliable and examination of a skin biopsy or molecular genetic testing is usually required to establish the diagnosis, especially in infants.</p>
        </sec>
        <sec id="ebj.Testing">
          <title>Testing</title>
          <p>Until recently, skin biopsies were needed to direct the clinician toward appropriate gene targets for variant analysis. See <xref ref-type="sec" rid="ebj.Testing_Strategy">Testing Strategy</xref> for discussion of molecular genetic testing options to confirm a diagnosis in an individual suspected of having JEB.</p>
          <p><bold>Skin biopsy.</bold> Examination of a skin biopsy by transmission electron microscopy (TEM) and/or immunofluorescent antibody/antigen mapping is one way to reliably establish a diagnosis of JEB. A punch biopsy that includes the full basement membrane zone is preferred. The biopsy should be taken from the leading edge of a fresh (&#x0003c;12 hours old) or a mechanically induced blister and should include some normal adjacent skin. Older blisters undergo change that may obscure the diagnostic morphology and can be misleading.</p>
          <p>Note:</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>For TEM:</p>
              <list list-type="alpha-lower">
                <list-item>
                  <label>a</label>
                  <p>Specimens must be placed in fixation medium (such as gluteraldehyde) as designated by the laboratory performing the test.</p>
                </list-item>
                <list-item>
                  <label>b</label>
                  <p>Formaldehyde-fixed samples cannot be used for electron microscopy</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <label>2</label>
              <p>For immunofluorescent antibody/antigen mapping:</p>
              <list list-type="alpha-lower">
                <list-item>
                  <label>a</label>
                  <p>Specimens should be sent in sterile carrying medium (such as Michel's of Zeus) as specified by the laboratory performing the test.</p>
                </list-item>
                <list-item>
                  <label>b</label>
                  <p>Some laboratories prefer flash-frozen tissue.</p>
                </list-item>
                <list-item>
                  <label>c</label>
                  <p>In some laboratories the mapping only designates the level of the cleavage by using various antibodies which mark different layers of the basement membrane. A specialized laboratory that has antigens for the proteins of interest in EB is preferred because both the level of cleavage and the presence or absence of the specific gene products mutated in EB can be assessed. Caution should be exercised NOT to send specimens labeled simply &#x0201c;for immunofluorescence&#x0201d; to a routine laboratory which is likely to stain for immunoglobulins and complement, both of which are irrelevant for the diagnosis of EB.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <label>3</label>
              <p>Light microscopy is inadequate and unacceptable for the accurate diagnosis of EB.</p>
            </list-item>
          </list>
          <p><bold>Transmission electron microscopy (TEM)</bold> is used to examine the number and morphology of basement membrane zone structures &#x02014; in particular, the number and morphology of anchoring fibrils, the presence of and morphology of hemidesmosomes, anchoring filaments, and keratin intermediate filaments as well as the presence of micro-vesicles showing the tissue cleavage plane.</p>
          <p>Findings on TEM include the following [<xref ref-type="bibr" rid="ebj.REF.kunz.2000.376">Kunz et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.jonkman.2002.1275">Jonkman et al 2002</xref>, <xref ref-type="bibr" rid="ebj.REF.charlesworth.2003.1344">Charlesworth et al 2003</xref>, <xref ref-type="bibr" rid="ebj.REF.pasmooij.2004a.669">Pasmooij et al 2004a</xref>, <xref ref-type="bibr" rid="ebj.REF.shinkuma.2011.412">Shinkuma et al 2011</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>In all forms of JEB.</bold> Splitting is seen in the lamina lucida of the basement membrane of the epidermis or just above the basement membrane at the level of the hemidesmosomes in the lowest level of the keratinocytes layer.</p>
            </list-item>
            <list-item>
              <p><bold>In Herlitz JEB (H-JEB).</bold> Hemidesmosomes are reduced in number and hypoplastic. Anchoring filaments are markedly reduced or absent.</p>
            </list-item>
            <list-item>
              <p><bold>In non-Herlitz JEB (NH-JEB).</bold> Anchoring filaments may be reduced; hemidesmosomes may be reduced or hypoplastic.</p>
            </list-item>
          </list>
          <p><bold>Immunofluorescent antibody/antigen mapping.</bold> Findings include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Abnormal or absent staining with antibodies to laminin 332 (aka LAM5) [<xref ref-type="bibr" rid="ebj.REF.aumailley.2005.326">Aumailley et al 2005</xref>] resulting from pathogenic variants in <italic toggle="yes">LAMA3</italic>, <italic toggle="yes">LAMB3</italic>, or <italic toggle="yes">LAMC2</italic> in Herlitz or non-Herlitz forms of JEB</p>
            </list-item>
            <list-item>
              <p>Abnormal or absent staining with antibodies to collagen XVII in JEB is caused by pathogenic variants in <italic toggle="yes">COL17A1</italic></p>
            </list-item>
          </list>
          <p>Note: Pathogenic variants in <italic toggle="yes">ITGB4, ITGA6</italic>, and <italic toggle="yes">PLEC1</italic> are causative of <related-object link-type="booklink" source-id="gene" document-id="eb-pa" document-type="chapter">epidermolysis bullosa with pyloric atresia</related-object> (EB-PA).</p>
          <p>Normal staining for other antigens (e.g., collagen VII, keratins 5 and 14) confirms the diagnosis of JEB.</p>
          <p>Note: Especially in milder forms of EB, indirect immunofluorescent studies may not be sufficient to make the diagnosis because near-normal antigen levels are detected and no cleavage plane is observed. In these cases electron microscopic examination of the skin biopsy must be performed. Alternatively, rebiopsy allowing more time (several hours) between rubbing of the skin (or the patient performing an activity that induces fresh blistering) and blister formation prior to biopsy for IFM or EM may be required.</p>
          <sec id="ebj.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold>
<italic toggle="yes">LAMB3</italic>, C<italic toggle="yes">OL17A1</italic>, <italic toggle="yes">LAMC2</italic>, and <italic toggle="yes">LAMA3</italic> are the four genes in which pathogenic variants are known to cause the two major phenotypes of JEB: Herlitz and non-Herlitz JEB [<xref ref-type="bibr" rid="ebj.REF.fine.1999">Fine et al 1999</xref>, <xref ref-type="bibr" rid="ebj.REF.antonlamprecht.2002">Anton-Lamprecht &#x00026; Gedde-Dahl 2002</xref>]:</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Sequence analysis</bold>
<bold><italic toggle="yes">LAMB3</italic>.</bold> Sequencing of <italic toggle="yes">LAMB3</italic> detects more than 98% of <italic toggle="yes">LAMB3</italic> pathogenic variants overall. Large deletions (i.e., exon and whole-gene deletions) have been identified in <italic toggle="yes">LAMB3</italic> in fewer than 1% of cases [<xref ref-type="bibr" rid="ebj.REF.pulkkinen.1995.77">Pulkkinen et al 1995</xref>, <xref ref-type="bibr" rid="ebj.REF.cserhalmifriedman.1998.105">Cserhalmi-Friedman et al 1998</xref>, <xref ref-type="bibr" rid="ebj.REF.takizawa.2000b.307">Takizawa et al 2000b</xref>, <xref ref-type="bibr" rid="ebj.REF.huber.2002.185">Huber et al 2002</xref>, <xref ref-type="bibr" rid="ebj.REF.micheloni.2004.796">Micheloni et al 2004</xref>, <xref ref-type="bibr" rid="ebj.REF.posteraro.2004.639">Posteraro et al 2004</xref>]. <bold><italic toggle="yes">COL17A1</italic>.</bold> Sequence analysis of <italic toggle="yes">COL17A1</italic> detects more than 98% of <italic toggle="yes">COL17A1</italic> pathogenic variants overall. <bold><italic toggle="yes">LAMC2</italic>.</bold> Sequence analysis of <italic toggle="yes">LAMC2</italic> detects more than 98% of <italic toggle="yes">LAMC2</italic> pathogenic variants overall. <bold><italic toggle="yes">LAMA3</italic>.</bold> Sequence analysis of <italic toggle="yes">LAMA3</italic> detects more than 98% of <italic toggle="yes">LAMA3</italic> pathogenic variants overall.</p>
              </list-item>
            </list>
            <table-wrap id="ebj.T.summary_of_molecular_genetic_testi" position="anchor" orientation="portrait">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Junctional Epidermolysis Bullosa</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of JEB Attributed to Mutation of This Gene&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>3,&#x000a0;4</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">LAMB3</italic>
                    </td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="3" valign="middle" align="left" colspan="1">70%</td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Exon/whole-gene deletions&#x000a0;<sup>7</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Targeted analysis for pathogenic variants&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Targeted variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">COL17A1</italic>
                    </td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">12%</td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Exon/whole-gene deletions&#x000a0;<sup>7</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">LAMC2</italic>
                    </td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="3" valign="middle" align="left" colspan="1">9%</td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Exon/whole-gene deletions&#x000a0;<sup>7</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Targeted analysis for pathogenic variants&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Targeted variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">LAMA3</italic>
                    </td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="3" valign="middle" align="left" colspan="1">9%</td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Sequence variants&#x000a0;<sup>9</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Exon/whole-gene deletions&#x000a0;<sup>7</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Targeted analysis for pathogenic variants&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_ebj.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Targeted variants</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="ebj.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="ebj" object-id="ebj.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="ebj.TF.1.2">
                  <label>2. </label>
                  <p>
                    <xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al [2006]</xref>
                  </p>
                </fn>
                <fn id="ebj.TF.1.3">
                  <label>3. </label>
                  <p>See <xref ref-type="sec" rid="ebj.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="ebj.TF.1.4">
                  <label>4. </label>
                  <p>Sequencing of all four genes results in a variant detection frequency of 98%. Large deletions and intronic variations that alter splicing are thought to be responsible for the other 2%.</p>
                </fn>
                <fn id="ebj.TF.1.5">
                  <label>5. </label>
                  <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="ebj.TF.1.6">
                  <label>6. </label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="ebj.TF.1.7">
                  <label>7. </label>
                  <p><xref ref-type="bibr" rid="ebj.REF.pulkkinen.1997.611">Pulkkinen et al [1997]</xref>, <xref ref-type="bibr" rid="ebj.REF.takizawa.2000b.307">Takizawa et al [2000b]</xref>, <xref ref-type="bibr" rid="ebj.REF.fassihi.2005.71">Fassihi et al [2005]</xref>, <xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al [2006]</xref></p>
                </fn>
                <fn id="ebj.TF.1.8">
                  <label>8. </label>
                  <p>Targeted analysis for pathogenic variants should be the first step for individuals of specific ethnic groups (see <xref ref-type="sec" rid="ebj.Testing_Strategy">Testing Strategy</xref>, <bold>Targeted molecular genetic testing</bold>).</p>
                </fn>
                <fn id="ebj.TF.1.9">
                  <label>9. </label>
                  <p>Care must be taken to sequence the genomic region of the longest transcript of <italic toggle="yes">LAMA3</italic> rather than one of the shorter transcript variants.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="ebj.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <p><bold>Skin biopsy</bold> is one way to reliably establish a diagnosis of JEB and to direct the clinician toward the appropriate genes to target for variant analysis. Especially in newborns, a skin biopsy from a newly induced blister should be performed as soon as possible after initial evaluation. The skin biopsy should be analyzed for morphology by electron microscopy and/or for the basement membrane proteins by indirect immunofluorescence to suggest the appropriate genes to be tested.</p>
          <p>Note: Lethal forms of JEB resulting from <italic toggle="yes">COL17A1</italic> pathogenic variants have been described [<xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>, <xref ref-type="bibr" rid="ebj.REF.murrell.2007.1772">Murrell et al 2007</xref>]; thus the strict criteria of a lethal versus non-lethal form of JEB are not sufficient to define the order of molecular genetic testing.</p>
          <p><bold>Targeted molecular genetic testing.</bold> When any form of JEB is suspected, targeted analysis for pathogenic variants should be the first step for individuals of the following ethnic groups:</p>
          <list list-type="bullet">
            <list-item>
              <p>European origin: <italic toggle="yes">LAMB3</italic> (<xref ref-type="table" rid="ebj.T.lamb3_pathogenic_variants_discusse">p.Arg635Ter</xref>, <xref ref-type="table" rid="ebj.T.lamb3_pathogenic_variants_discusse">p.Gln243Ter</xref>)</p>
            </list-item>
            <list-item>
              <p>Hispanic and African American: <italic toggle="yes">LAMB3</italic> (<xref ref-type="table" rid="ebj.T.lamb3_pathogenic_variants_discusse">c.957ins77</xref>, <xref ref-type="table" rid="ebj.T.lamb3_pathogenic_variants_discusse">p.Arg42Ter</xref>)</p>
            </list-item>
            <list-item>
              <p>Pakistani: <italic toggle="yes">LAMA3</italic> (<xref ref-type="table" rid="ebj.T.lama3_pathogenic_variants_discusse">p.Arg650Ter</xref>) [<xref ref-type="bibr" rid="ebj.REF.mcgrath.1996.781">McGrath et al 1996</xref>]</p>
            </list-item>
            <list-item>
              <p>Italian: <italic toggle="yes">LAMC2</italic> (<xref ref-type="table" rid="ebj.T.lamc2_pathogenic_variants_discusse">p.Arg95Ter</xref>) [<xref ref-type="bibr" rid="ebj.REF.posteraro.2004.639">Posteraro et al 2004</xref>]</p>
            </list-item>
          </list>
          <p>These pathogenic variants may account for up to 45% of JEB-causing variants.</p>
          <p><bold>Sequential gene sequence analysis.</bold> If neither or only one pathogenic variant is identified in an individual with biopsy-proven <bold>Herlitz JEB</bold> following targeted analysis, sequence analysis of the four known genes has the following variant detection frequencies [<xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">LAMB3</italic>: 25%</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">LAMC2</italic>: 9%</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">LAMA3</italic>: 10%</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">COL17A1</italic>: 8%</p>
            </list-item>
          </list>
          <p>If neither or only one pathogenic variant is identified in an individual with biopsy-proven <bold>non-Herlitz JEB</bold> following targeted analysis, sequence analysis of the four known genes has the following variant detection frequencies [<xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">LAMB3</italic>: 25%</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">COL17A1</italic>: 25%</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">LAMC2</italic>: 3%</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">LAMA3</italic>: 8%</p>
            </list-item>
          </list>
          <p>If no pathogenic variants are identified in the four genes listed above, it is appropriate to consider molecular genetic testing of genes that lead to a JEB-like phenotype (including <italic toggle="yes">ITGB4</italic> and <italic toggle="yes">PLEC1</italic>; see <xref ref-type="sec" rid="ebj.Differential_Diagnosis">Differential Diagnosis</xref>, EB-PA) [<xref ref-type="bibr" rid="ebj.REF.inoue.2000.1061">Inoue et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.kunz.2000.376">Kunz et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.charlesworth.2003.1344">Charlesworth et al 2003</xref>] or a multi-gene panel that includes genes known to lead to JEB and JEB-like phenotypes.</p>
          <p><bold>Multi-gene panel analysis.</bold> An alternative to skin biopsy with targeted genetic testing and sequential genetic testing is use of a multi-gene panel. Multi-gene panels can be used for simultaneous analysis of multiple genes known to be involved in the pathogenesis of EB and related conditions. These panels vary by methods used and genes included; thus, the ability of a panel to detect a causative pathogenic variant or variants in any given individual also varies.</p>
          <p><bold>Carrier testing for at-risk relatives (in families with autosomal recessive inheritance)</bold> requires prior identification of the pathogenic variants in the family.</p>
          <p>Note: Carriers are heterozygotes for an autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant(s) in the family.</p>
        </sec>
      </sec>
      <sec id="ebj.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="ebj.Clinical_Description">
          <title>Clinical Description</title>
          <p>Before the molecular basis of junctional epidermolysis bullosa (JEB) was understood, subtypes were identified (see <xref ref-type="sec" rid="ebj.Nomenclature">Nomenclature</xref>) based primarily on clinical features, mode of inheritance, and the presence or absence of laminin 5 and anchoring filaments on skin biopsy. Broad classification of JEB includes H-JEB (aka lethal) and NH-JEB (aka non-lethal) and is based on severity and survival past the first years of life [<xref ref-type="bibr" rid="ebj.REF.fine.1999">Fine et al 1999</xref>, <xref ref-type="bibr" rid="ebj.REF.pulkkinen.1999.29">Pulkkinen &#x00026; Uitto 1999</xref>, <xref ref-type="bibr" rid="ebj.REF.irvine.2003.1">Irvine &#x00026; McLean 2003</xref>, <xref ref-type="bibr" rid="ebj.REF.uitto.2005.33">Uitto &#x00026; Richard 2005</xref>, <xref ref-type="bibr" rid="ebj.REF.yuen.2013.93">Yuen et al 2013</xref>, <xref ref-type="bibr" rid="ebj.REF.kellymancuso.2014.159">Kelly-Mancuso et al 2014</xref>].</p>
          <p><bold>Herlitz JEB (H-JEB).</bold> In this classic severe form of JEB, blisters are present at birth or become apparent in the neonatal period [<xref ref-type="bibr" rid="ebj.REF.laimer.2010.55">Laimer et al 2010</xref>].</p>
          <p>Blistering is very severe and may lead to large regions of affected skin with significant granulation tissue. Granulation tissue characteristically appears around the nose, mouth, ears, and tips of the fingers and toes as well as in areas subject to friction such as the buttocks and the back of the head. Persistent plaques on the face can be challenging to treat. The granulation tissue manifests as large eroded patches and plaques often with serpiginous or annular borders that are friable and bleed easily and profusely. There can be extensive loss of blood, fluid, and protein. Such erosions are often life threatening because they make these infants susceptible to electrolyte imbalance and infection including sepsis and sudden death. If the infant survives, blistering may continue throughout life, generally without scarring unless there has been severe secondary infection. Scarring pseudosyndactyly of the hands and feet fusing the digits into "mitten" hands and feet with severe loss of function has been seen in the very few individuals with H-JEB who survive [<xref ref-type="bibr" rid="ebj.REF.fine.1999">Fine et al 1999</xref>].</p>
          <p>In addition to cutaneous involvement, mucosal involvement of the mouth, upper respiratory tract, esophagus, bladder, urethra, and corneas can be seen. Accumulation of granulation tissue surrounding the airway is usually subglottic and the first manifestation is a weak, hoarse cry. Eventually, compression and obstruction of the airway result in stridor and respiratory distress. Unless tracheostomy is performed, many children succumb from respiratory complications. However, managing a tracheostomy in a child with such fragile skin is difficult [<xref ref-type="bibr" rid="ebj.REF.ida.2012.657">Ida et al 2012</xref>].</p>
          <p>Bladder and urethral epithelial involvement can cause dysuria, urinary retention, urinary tract infections, and eventual renal compromise. Renal and ureteral anomalies that can be seen include dysplastic/multicystic kidney, hydronephrosis/hydroureter, acute renal tubular necrosis, obstructive uropathy, ureterocele, duplicated renal collecting system, and absent bladder [<xref ref-type="bibr" rid="ebj.REF.puvabanditsin.1997.359">Puvabanditsin et al 1997</xref>, <xref ref-type="bibr" rid="ebj.REF.kambham.2000.190">Kambham et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.nakano.2000.493">Nakano et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.wallerstein.2000.286">Wallerstein et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.fine.2004.651">Fine et al 2004</xref>, <xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>, <xref ref-type="bibr" rid="ebj.REF.pfendner.2007.781">Pfendner et al 2007</xref>].</p>
          <p>Esophageal narrowing has been reported, but is less common than in children with recessive dystrophic EB (RDEB).</p>
          <p>Secondary complications common in H-JEB include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Growth retardation from malnutrition as a result of poor intake and an increased nutritional demand for tissue healing</p>
            </list-item>
            <list-item>
              <p>Anemia</p>
            </list-item>
            <list-item>
              <p>Alopecia</p>
            </list-item>
            <list-item>
              <p>Cutaneous infection</p>
            </list-item>
            <list-item>
              <p>Sepsis</p>
            </list-item>
            <list-item>
              <p>Electrolyte imbalance</p>
            </list-item>
            <list-item>
              <p>Osteoporosis [<xref ref-type="bibr" rid="ebj.REF.fewtrell.2006.959">Fewtrell et al 2006</xref>]</p>
            </list-item>
            <list-item>
              <p>Dilated cardiomyopathy</p>
            </list-item>
            <list-item>
              <p>Urologic and renal complications</p>
            </list-item>
            <list-item>
              <p>Squamous cell carcinoma [<xref ref-type="bibr" rid="ebj.REF.yuen.2011.780">Yuen &#x00026; Jonkman 2011</xref>]</p>
            </list-item>
            <list-item>
              <p>Enamel dysplasia with pitting of the teeth [<xref ref-type="bibr" rid="ebj.REF.kr_mer.2010.303">Kr&#x000e4;mer 2010</xref>, <xref ref-type="bibr" rid="ebj.REF.stellingsma.2011.405">Stellingsma et al 2011</xref>]</p>
            </list-item>
          </list>
          <p>Most children with H-JEB do not survive past the first year of life.</p>
          <p><bold>Non-Herlitz JEB (NH-JEB).</bold> A spectrum of JEB clinical phenotypes, all of which are less severe than classic H-JEB, comprises NH-JEB. The phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal, ureteral, or esophageal involvement or relatively more widespread including flexural areas and trunk.</p>
          <p>Some children virtually never blister after the newborn period. The severe granulation tissue and respiratory compromise of H-JEB are rare.</p>
          <p>Varying degrees of alopecia and onychodystrophy as well as tooth pitting remain hallmarks of this type of JEB.</p>
          <p><bold>Manifestations that can occur in H-JEB, NH-JEB, and</bold>
<related-object link-type="booklink" source-id="gene" document-id="eb-pa" document-type="chapter"><bold>EB with pyloric atresia</bold></related-object>
<bold>(EB-PA) as well as</bold>
<related-object link-type="booklink" source-id="gene" document-id="ebd" document-type="chapter"><bold>dystrophic epidermolysis bullosa</bold></related-object>
<bold>(DEB) and</bold>
<related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter"><bold>epidermolysis bullosa simplex</bold></related-object>
<bold>(EBS).</bold> The following manifestations are now recognized to be found in the major EB types as described in the findings of the National EB Registry [<xref ref-type="bibr" rid="ebj.REF.fine.1999">Fine et al 1999</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Congenital localized absence of skin (aplasia cutis congenita)</bold> can be seen in any of the major types of EB and is not a discriminating diagnostic feature of any of these types of EB in general or any subtype of JEB. Congenital absence of skin on the extremities had been classified as Bart syndrome (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/132000">OMIM</ext-link>) but currently is considered a manifestation of all types of EB.</p>
            </list-item>
            <list-item>
              <p><bold>Milia</bold> are small white-topped papules; they are often confused with epidermal cysts and are not confined to any type of EB, although they are most common in individuals with DEB.</p>
            </list-item>
            <list-item>
              <p><bold>Nail dystrophy</bold> is defined as changes in size, color, shape, or texture of nails and is not confined to any one form of EB.</p>
            </list-item>
            <list-item>
              <p><bold>Scarring alopecia</bold> is defined as complete loss of scalp hair follicles as a result of scarring and loss of hair follicles. Scarring alopecia is more prevalent in JEB and DEB but is not confined solely to any one form of EB.</p>
            </list-item>
            <list-item>
              <p><bold>Hypotrichosis</bold> is defined as reduction in the number of hair follicles in a given area compared to the number of hair follicles in the same area of a normal individual of the same gender. Hypotrichosis is not confined to any one form of EB.</p>
            </list-item>
            <list-item>
              <p><bold>Pseudosyndactyly and other contractures.</bold> Pseudosyndactyly is defined as the partial or complete loss of web spaces between any digits of the hands or feet. "Other contractures" refers to loss of mobility of any other joints as a result of fibrous tissue scars. Although these changes are more prevalent in DEB, they have also been observed occasionally in the other forms of EB.</p>
            </list-item>
            <list-item>
              <p><bold>Scarring</bold> is not confined to any form of EB and has been observed in 30% of those with EBS, 76% of those with JEB, and up to 98% of those with DEB.</p>
            </list-item>
            <list-item>
              <p><bold>Exuberant granulation tissue,</bold> previously thought to be confined to those with JEB (23%), has now been observed in a small percentage of those with DEB (&#x02264;12%) and EBS (0.7%). This finding is misleading because it does not usually appear until the affected child is a few years old and most children with H-JEB do not survive that long.</p>
            </list-item>
          </list>
        </sec>
        <sec id="ebj.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><bold>H-JEB.</bold> The severest forms of H-JEB are a result of inactivating variants on both alleles, which result in little or no functional protein [<xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>]. For frameshift variants, the severity may be related to the position of the stop codon; however, the presence of some functional protein appears to be the most important factor in mitigating disease severity.</p>
          <p>Less severe forms of H-JEB generally result from other amino acid substitutions and splice-junction variants, although it is difficult to generalize because of the wide phenotypic variability and range of allelic variants that has been identified [<xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>]. In addition, moderation of phenotypes expected to be severe has occurred through in-frame skipping of exons containing nonsense or frameshift variants [<xref ref-type="bibr" rid="ebj.REF.mcgrath.1999.314">McGrath et al 1999</xref>].</p>
        </sec>
        <sec id="ebj.Penetrance">
          <title>Penetrance</title>
          <p>Pathogenic variants in <italic toggle="yes">LAMB3</italic>, <italic toggle="yes">LAMA3</italic>, <italic toggle="yes">LAMC2</italic>, and <italic toggle="yes">COL17A1</italic> are 100% penetrant in individuals who have two variants on different alleles in the same gene.</p>
        </sec>
        <sec id="ebj.Anticipation">
          <title>Anticipation</title>
          <p>Genetic anticipation is not observed in junctional epidermolysis bullosa.</p>
        </sec>
        <sec id="ebj.Nomenclature">
          <title>Nomenclature</title>
          <p>The following hierarchy includes as synonyms specific designations for JEB that have been used in the past. Designations in current use are in <bold>boldface</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Junctional epidermolysis bullosa, Herlitz</bold> (synonyms: epidermolysis bullosa letalis; epidermolysis bullosa junctional Herlitz-Pearson; junctional epidermolysis bullosa mitis)In descending order of frequency:</p>
              <list list-type="bullet">
                <list-item>
                  <p>
                    <bold><italic toggle="yes">LAMB3</italic>-related junctional epidermolysis bullosa</bold>
                  </p>
                </list-item>
                <list-item>
                  <p>
                    <bold><italic toggle="yes">LAMC2</italic>-related junctional epidermolysis bullosa</bold>
                  </p>
                </list-item>
                <list-item>
                  <p>
                    <bold><italic toggle="yes">LAMA3</italic>-related junctional epidermolysis bullosa</bold>
                  </p>
                </list-item>
                <list-item>
                  <p>
                    <bold><italic toggle="yes">COL17A1</italic>-related junctional epidermolysis bullosa</bold>
                  </p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Junctional epidermolysis bullosa, non-Herlitz</bold> (synonyms: epidermolysis bullosa, generalized atrophic benign (GABEB); epidermolysis bullosa junctionalis, disentis type; epidermolysis bullosa junctionalis, progressive; epidermolysis bullosa junctionalis, severe non-lethal) In descending order of frequency:</p>
              <list list-type="bullet">
                <list-item>
                  <p>
                    <bold><italic toggle="yes">LAMB3</italic>-related junctional epidermolysis bullosa</bold>
                  </p>
                </list-item>
                <list-item>
                  <p>
                    <bold><italic toggle="yes">COL17A1</italic>-related junctional epidermolysis bullosa</bold>
                  </p>
                </list-item>
                <list-item>
                  <p>
                    <bold><italic toggle="yes">LAMC2</italic>-related junctional epidermolysis bullosa</bold>
                  </p>
                </list-item>
                <list-item>
                  <p>
                    <bold><italic toggle="yes">LAMA3</italic>-related junctional epidermolysis bullosa</bold>
                  </p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Generalized atrophic benign EB (GABEB), originally described as a separate clinical entity caused by pathogenic variants in <italic toggle="yes">COL17A1</italic>, is now included within the NH-JEB category because of significant phenotypic overlap.</p>
        </sec>
        <sec id="ebj.Prevalence">
          <title>Prevalence</title>
          <p>According to the National EB Registry, prevalence of all types of JEB is 0.44 per million in the US population [<xref ref-type="bibr" rid="ebj.REF.fine.1999">Fine et al 1999</xref>]. Recent data estimate the incidence of JEB to be at least 3.59 per million per year with a 73% mortality rate.</p>
          <list list-type="bullet">
            <list-item>
              <p>H-JEB prevalence is estimated at 0.4 per million but may be underrepresented. JEB incidence is also very low (0.41 per million), but is probably underestimated: many Herlitz cases go unreported because infants succumb to the disease in the neonatal period. H-JEB prevalence is also low because most affected children die in early infancy.</p>
            </list-item>
            <list-item>
              <p>NH-JEB incidence is 2.0 per million.</p>
            </list-item>
          </list>
          <p>Carrier risk of all forms of JEB in the US population has been calculated as 1:350.</p>
          <list list-type="bullet">
            <list-item>
              <p>Carrier risk of H-JEB has been calculated as 1:781 [<xref ref-type="bibr" rid="ebj.REF.nakano.2000.493">Nakano et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.pfendner.2001.483">Pfendner et al 2001</xref>].</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="ebj.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">LAMB3</italic>.</bold>
<italic toggle="yes">LAMB3</italic> pathogenic variants are associated with hypoplastic amelogenesis imperfecta [<xref ref-type="bibr" rid="ebj.REF.poulter.2014.132">Poulter et al 2014</xref>].</p>
        <p><bold><italic toggle="yes">LAMA3</italic>.</bold> A related disorder, laryngoonychocutaneous (LOC or Shabbir) syndrome, or LOCS (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/245660">OMIM</ext-link>) is described in Punjabi Indians. LOCS has many phenotypic characteristics similar to NH-JEB [<xref ref-type="bibr" rid="ebj.REF.figueira.2007.163">Figueira et al 2007</xref>, <xref ref-type="bibr" rid="ebj.REF.pfendner.2007.781">Pfendner et al 2007</xref>]. Skin fragility manifests as mild blistering and erosions of the hands and face that spread to other parts of the body and heal with crusted lesions. Neonates may have a hoarse cry and later laryngeal abnormalities and growths, conjunctival disease, abnormal nails, and hypoplastic dental enamel. Eventually, conjunctival disease may cause blindness and laryngeal disease may cause life-threatening airway obstruction requiring tracheotomy [<xref ref-type="bibr" rid="ebj.REF.cohn.2010.89">Cohn &#x00026; Murrell 2010</xref>].</p>
        <p>The <italic toggle="yes">LAMA3</italic> pathogenic variant <xref ref-type="table" rid="ebj.T.lama3_pathogenic_variants_discusse">c.151insG</xref> in exon 39, one of three <italic toggle="yes">LAMA3</italic> isoforms, is causative [<xref ref-type="bibr" rid="ebj.REF.mclean.2003.2395">McLean et al 2003</xref>]. Inheritance is autosomal recessive.</p>
        <p>Diagnosis of LOCS may be complicated by the lack of a definitive cleavage plane on TEM and reduced but not absent laminin 5 staining by immunofluorescence for the basement membrane proteins. Sequence analysis of all 76 exons of <italic toggle="yes">LAMA3</italic>, which encodes all three isoforms, is necessary to provide a definitive diagnosis, especially in neonates.</p>
        <p><bold><italic toggle="yes">COL17A1</italic>.</bold> Pathogenic variants in <italic toggle="yes">COL17A1</italic> may also be associated with an epidermal keratinocyte cleavage plane usually associated with <related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter">epidermolysis bullosa simplex</related-object> (EBS) [<xref ref-type="bibr" rid="ebj.REF.pasmooij.2004a.669">Pasmooij et al 2004a</xref>].</p>
        <p><bold><italic toggle="yes">LAMC2.</italic></bold> No phenotypes other than JEB are known to be associated with pathogenic variants in <italic toggle="yes">LAMC2</italic>.</p>
      </sec>
      <sec id="ebj.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The four major types of EB, caused by pathogenic variants in 14 different genes, are <related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter">epidermolysis bullosa simplex</related-object> (EBS), junctional epidermolysis bullosa (JEB), <related-object link-type="booklink" source-id="gene" document-id="ebd" document-type="chapter">dystrophic epidermolysis bullosa</related-object> (DEB), and <related-object link-type="booklink" source-id="gene" document-id="kindler" document-type="chapter">Kindler syndrome</related-object>. The diagnostic criteria describing the major types and rarer subtypes of EB have recently been expanded to include Kindler syndrome, laryngo-oculo-cutaneous syndrome, and a number of rare forms of EBS [<xref ref-type="bibr" rid="ebj.REF.fine.2009.203">Fine et al 2009</xref>, <xref ref-type="bibr" rid="ebj.REF.intong.2012.70">Intong &#x00026; Murrell 2012</xref>]. The diagnostic criteria are designed to encompass other new blistering disorders as they are discovered. Excellent clinical reviews include the chapter on EB in <italic toggle="yes">Principles and Practice of Medical Genetics</italic> [<xref ref-type="bibr" rid="ebj.REF.antonlamprecht.2002">Anton-Lamprecht &#x00026; Gedde-Dahl 2002</xref>] and <italic toggle="yes">Fine's Revised Classification System</italic> [<xref ref-type="bibr" rid="ebj.REF.fine.1999">Fine et al 1999</xref>, <xref ref-type="bibr" rid="ebj.REF.fine.2000.1051">Fine et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.fine.2008.677">Fine et al 2008</xref>].</p>
        <p>The four major types of EB share fragility of the skin, manifested by blistering with little or no trauma. A positive Nikolsky sign (blistering of uninvolved skin after rubbing) is common to all types of EB. No clinical findings are specific to a given type; thus, establishing the type of EB requires either a fresh skin biopsy from a newly induced blister that is stained by indirect immunofluorescence for critical basement membrane protein components or molecular genetic confirmation of the diagnosis. When using skin biopsy, the diagnosis is established by determining the cleavage plane on TEM and the presence/absence of these protein components by immunofluorescent antibody/antigen mapping and their distribution. Electron microscopy is also diagnostic and often more useful in milder forms of EB.</p>
        <p>Clinical examination is useful in determining the extent of blistering, the presence of oral and other mucous membrane lesions, and the presence and extent of scarring.</p>
        <p>Limitations of the clinical findings in establishing the type of EB include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>In young children and neonates the extent and severity of blistering and scarring may not be established or significant enough to allow identification of EB type.</p>
          </list-item>
          <list-item>
            <p>Mucosal and nail involvement and the presence or absence of milia may not be helpful discriminators (see <xref ref-type="sec" rid="ebj.Clinical_Characteristics">Clinical Characteristics</xref>).</p>
          </list-item>
          <list-item>
            <p>Post-inflammatory changes such as those seen in EBS, Dowling-Meara type (EBS-DM) are often mistaken for scarring or mottled pigmentation.</p>
          </list-item>
          <list-item>
            <p>Scarring can occur in EBS and JEB as a result of infection of erosions or scratching, which further damages the exposed surface.</p>
          </list-item>
          <list-item>
            <p>Congenital absence of the skin can be seen in any of the types of EB and is not a discriminating diagnostic feature (see <xref ref-type="sec" rid="ebj.Clinical_Characteristics">Clinical Characteristics</xref>).</p>
          </list-item>
        </list>
        <p>Clinical findings that tend to be characteristic for a specific type of EB include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Corneal erosions, esophageal strictures, and nail involvement may indicate DEB.</p>
          </list-item>
          <list-item>
            <p>Blistering and scarring limited to the hands and feet in milder cases suggests autosomal dominant DEB (DDEB).</p>
          </list-item>
          <list-item>
            <p>Pseudosyndactyly (mitten deformities) and contractures in older children and adults usually suggests autosomal recessive DEB (RDEB).</p>
          </list-item>
          <list-item>
            <p>Hoarseness and respiratory distress suggest H-JEB.</p>
          </list-item>
          <list-item>
            <p>Granulation tissue suggests JEB.</p>
          </list-item>
          <list-item>
            <p>Hyperkeratosis of the palms and soles suggests EBS, especially the DM type.</p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter"><bold>Epidermolysis bullosa simplex</bold></related-object>
<bold>(EBS)</bold> is characterized by fragility of the skin (and mucosal epithelia in some cases) that results in nonscarring blisters caused by little or no trauma. The current classification of epidermolysis bullosa (EB) includes two major types and 12 minor subtypes of EBS; all share the common feature of blistering above the dermal-epidermal junction at the ultrastructural level. The four most common subtypes of EBS are:</p>
        <list list-type="bullet">
          <list-item>
            <p>EBS, localized (EBS-loc; previously known as Weber-Cockayne type)</p>
          </list-item>
          <list-item>
            <p>EBS, Dowling-Meara type(EBS-DM)</p>
          </list-item>
          <list-item>
            <p>EBS, other generalized (EBS, gen-nonDM; previously known as Koebner type)</p>
          </list-item>
          <list-item>
            <p>EBS-with mottled pigmentation (EBS-MP)</p>
          </list-item>
        </list>
        <p>The phenotypes for these four subtypes of EBS range from relatively mild blistering of the hands and feet to more generalized blistering and extensive hyperkeratosis, which can be fatal.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>In EBS-loc</bold>, blisters are rarely present or minimal at birth and may occur on the knees and shins with crawling or on the feet at approximately age18 months; some individuals manifest the disease in adolescence or early adulthood. Blisters are usually confined to the hands and feet, but can occur anywhere if trauma is significant.</p>
          </list-item>
          <list-item>
            <p><bold>In EBS, gen-non DM</bold>, blisters may be present at birth or develop within the first few months of life. Involvement is more widespread than in EBS-loc, but generally milder than in EBS-DM.</p>
          </list-item>
          <list-item>
            <p><bold>In EBS-MP</bold>, skin fragility is evident at birth and clinically indistinguishable from EBS-DM; over time, progressive brown pigmentation interspersed with hypopigmented spots develops on the trunk and extremities, with the pigmentation disappearing in adult life. Focal palmar and plantar hyperkeratoses may occur.</p>
          </list-item>
          <list-item>
            <p><bold>In EBS-DM</bold>, onset is usually at birth; severity varies greatly, both within and among families. Widespread and severe blistering and/or multiple grouped clumps of small blisters are typical and hemorrhagic blisters are common. Improvement occurs during mid- to late childhood. EBS-DM appears to improve with warmth in some individuals. Progressive hyperkeratosis of the palms and soles begins in childhood and may be the major complaint of affected individuals in adult life. Nail dystrophy and milia are common. Both hyper- and hypopigmentation can occur. Mucosal involvement in EBS-DM may interfere with feeding. Blistering can be severe enough to result in neonatal or infant death.</p>
          </list-item>
        </list>
        <p><bold>Other subtypes of EB</bold>
<bold>simplex</bold>
<bold>(EBS</bold>). The current classification system divides EBS into two subtypes based on the location of blistering in the epidermis. In the <bold>suprabasal</bold> forms of EBS, blistering occurs above the basal keratinocytes. The suprabasal forms of EBS are extremely rare and include: EBS superficialis; EBS, plakophilin-1 deficiency (also called ectodermal dysplasia/skin fragility syndrome); and EBS, lethal acantholytic.</p>
        <list list-type="bullet">
          <list-item>
            <p>EBS, plakophilin-1 deficiency is characterized by mild skin fragility associated with perioral cracking and cheilitis, hypotrichosis or alopecia, and a painful and fissured palmoplantar keratoderma; it is caused by loss-of-function variants in <italic toggle="yes">PKP1</italic> (for review, see <xref ref-type="bibr" rid="ebj.REF.mcgrath.2010.125">McGrath &#x00026; Mellerio [2010]</xref>).</p>
          </list-item>
          <list-item>
            <p>EBS, lethal acantholytic is caused by pathogenic variants in the tail region of <italic toggle="yes">DSP</italic>, which encodes desmoplakin [<xref ref-type="bibr" rid="ebj.REF.jonkman.2005.653">Jonkman et al 2005</xref>, <xref ref-type="bibr" rid="ebj.REF.bolling.2010.1388">Bolling et al 2010</xref>, <xref ref-type="bibr" rid="ebj.REF.hobbs.2010.2680">Hobbs et al 2010</xref>]. Affected neonates present with progressive erosions without blistering, alopecia, and loss of nails. Death within the first days after birth secondary to profound fluid and electrolyte imbalance is common.</p>
          </list-item>
        </list>
        <p><bold>Hemidesmosomal EB.</bold>
<xref ref-type="bibr" rid="ebj.REF.pulkkinen.1999.29">Pulkkinen &#x00026; Uitto [1999]</xref> proposed that EB with muscular dystrophy (EB-MD) and EB with pyloric atresia (EB-PA) be considered "hemidesmosomal JEB" because the involved proteins are located in the hemidesmosomes. Within basal keratinocytes, plectin is localized to the inner plaques of the hemidesmosomes, which are hypoplastic and show poor association with keratin filaments. Electron microscopy of skin biopsies reveals a plane of cleavage (level of separation) within the bottom layer of the basal keratinocytes, just above the hemidesmosomes. (See <related-object link-type="booklink" source-id="gene" document-id="eb-pa" document-type="chapter">EB-PA</related-object>.)</p>
        <p>However, "hemidesmosomal epidermolysis bullosa" is not a universally accepted designation and is not included in the 2008 classification of EB; the following three types typically have been included either with EBS (caused by biallelic pathogenic variants in <italic toggle="yes">PLEC1</italic>, <italic toggle="yes">ITGA6</italic>, or <italic toggle="yes">ITGB4</italic>) or with JEB (caused by biallelic pathogenic variants in <italic toggle="yes">ITGA6</italic> or <italic toggle="yes">ITGB4</italic>):</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>EB-MD</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/226670">OMIM</ext-link>). Approximately 50 cases of EB-MD have been reported worldwide. Some persons with EB as a result of <italic toggle="yes">PLEC1</italic> mutation develop muscular dystrophy [<xref ref-type="bibr" rid="ebj.REF.smith.1996.450">Smith et al 1996</xref>, <xref ref-type="bibr" rid="ebj.REF.charlesworth.2003.1344">Charlesworth et al 2003</xref>, <xref ref-type="bibr" rid="ebj.REF.kossharnes.2004.124">Koss-Harnes et al 2004</xref>, <xref ref-type="bibr" rid="ebj.REF.schara.2004.218">Schara et al 2004</xref>, <xref ref-type="bibr" rid="ebj.REF.pfendner.2005.241">Pfendner et al 2005</xref>]. Blistering occurs early and is generally mild. Muscular dystrophy may not appear until later childhood, adolescence, or in some cases adulthood, and can cause immobility and eventually death later in life. Pathogenic variants have been described throughout <italic toggle="yes">PLEC1</italic> but seem to cluster in the two long open reading frames containing exons in the 3' end of the gene. Nonsense, missense, insertion/deletion, and splice-junction variants have been described. The mildest phenotypes are usually associated with in-frame insertions or deletions, which do not alter the reading frame of the microRNA (mRNA) [<xref ref-type="bibr" rid="ebj.REF.pfendner.2005.241">Pfendner et al 2005</xref>]. Inheritance is autosomal recessive. A lethal case of autosomal recessive EBS as a result of <italic toggle="yes">PLEC1</italic> pathogenic variants has also been described [<xref ref-type="bibr" rid="ebj.REF.charlesworth.2003.1344">Charlesworth et al 2003</xref>]. <xref ref-type="bibr" rid="ebj.REF.kunz.2000.376">Kunz et al [2000]</xref> also described a case of EBS with severe mucous membrane involvement as a result of pathogenic variants in <italic toggle="yes">PLEC1</italic>. EBS caused by variants in <italic toggle="yes">PLEC1</italic> can vary from relatively mild, previously known as the Ogna form (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/131950">OMIM</ext-link>) [<xref ref-type="bibr" rid="ebj.REF.kossharnes.2002.87">Koss-Harnes et al 2002</xref>], to more severe and sometimes lethal [<xref ref-type="bibr" rid="ebj.REF.kunz.2000.376">Kunz et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.charlesworth.2003.1344">Charlesworth et al 2003</xref>]. Recent data indicates that up to 8% of EBS cases may be caused by mutation of <italic toggle="yes">PLEC1</italic> [<xref ref-type="bibr" rid="ebj.REF.bolling.2014.273">Bolling et al 2014</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="eb-pa" document-type="chapter"><bold>EB-PA</bold></related-object><bold>.</bold> In several US and Japanese families, EB with pyloric atresia is associated with premature termination variants in <italic toggle="yes">PLEC1</italic> [<xref ref-type="bibr" rid="ebj.REF.nakamura.2005.28">Nakamura et al 2005</xref>, <xref ref-type="bibr" rid="ebj.REF.pfendner.2005.111">Pfendner &#x00026; Uitto 2005</xref>], and more commonly, the gene encoding &#x003b2;4 integrin (<italic toggle="yes">ITGB4</italic>). Rare cases of EB-PA are associated with pathogenic variants in the &#x003b1;6 integrin gene (<italic toggle="yes">ITGA6</italic>). Although disease course is severe and often lethal in the neonatal period, non-lethal forms have been described. Individuals with pathogenic variants in the genes encoding &#x003b1;6 or &#x003b2;4 integrin may also show renal and ureteral anomalies, including dysplastic/multicystic kidney, hydronephrosis/hydroureter, acute renal tubular necrosis, obstructive uropathy, ureterocele, duplicated renal collecting system, and absent bladder [<xref ref-type="bibr" rid="ebj.REF.puvabanditsin.1997.359">Puvabanditsin et al 1997</xref>, <xref ref-type="bibr" rid="ebj.REF.kambham.2000.190">Kambham et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.nakano.2000.493">Nakano et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.wallerstein.2000.286">Wallerstein et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>, <xref ref-type="bibr" rid="ebj.REF.pfendner.2007.781">Pfendner et al 2007</xref>]. Occasionally, pyloric atresia may be suspected during gestation as a result of oligohydramnios, with or without elevated alpha-fetoprotein and acetylcholinesterase levels, and echogenic material in the amniotic fluid [<xref ref-type="bibr" rid="ebj.REF.dolan.1993.395">Dolan et al 1993</xref>, <xref ref-type="bibr" rid="ebj.REF.azarian.2006.57">Azarian et al 2006</xref>].</p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="ebd" document-type="chapter"><bold>Dystrophic EB</bold></related-object>
<bold>(DEB).</bold> The blister forms below the basement membrane, and the basement membrane is attached to the blister roof, resulting in scarring when blisters heal. Pathogenic variants in <italic toggle="yes">COL7A1</italic>, the gene encoding type VII collagen, have been demonstrated in all forms of DEB, both dominant and recessive [<xref ref-type="bibr" rid="ebj.REF.varki.2007.181">Varki et al 2007</xref>].</p>
      </sec>
      <sec id="ebj.Management">
        <title>Management</title>
        <sec id="ebj.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with junctional epidermolysis bullosa (JEB), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Evaluation of the sites of blister formation, including mouth, esophagus, and airway in a child with progressive hoarseness or stridor</p>
            </list-item>
            <list-item>
              <p>Direct examination of the airway by an experienced otolaryngologist with appropriately small and lubricated instruments to determine the extent of airway compromise so that decisions regarding tracheostomy can be discussed with the family</p>
            </list-item>
            <list-item>
              <p>Evaluation for gastroesophageal reflux disease which may cause additional trauma to the upper airway [<xref ref-type="bibr" rid="ebj.REF.ida.2012.657">Ida et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>Evaluation for existing osteopenia through skeletal radiographs or DEXA scan</p>
            </list-item>
            <list-item>
              <p>Evaluation for cardiomyopathy by clinical evaluation and/or echocardiogram [Fine et all 2008]</p>
            </list-item>
            <list-item>
              <p>Measurements of hemoglobin and electrolytes to evaluate for anemia and electrolyte imbalance</p>
            </list-item>
            <list-item>
              <p>Skin bacterial cultures and blood cultures in clinically ill infants to decide appropriate antibiotic treatment</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="ebj.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Skin.</bold> The skin needs to be protected from shearing forces and caretakers need to learn how to handle the child with EB [<xref ref-type="bibr" rid="ebj.REF.denyer.2010.257">Denyer 2010</xref>, <xref ref-type="bibr" rid="ebj.REF.pope.2012.904">Pope et al 2012</xref>].</p>
          <p>New blisters should be lanced and drained to prevent further spread from fluid pressure. In most cases, dressings for blisters involve three layers:</p>
          <list list-type="bullet">
            <list-item>
              <p>A primary non-adherent dressing that does not strip the top layers of the epidermis. Tolerance to different primary layers varies. Primary layers include the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>OrdinaryBand-Aids<sup>&#x000ae;</sup></p>
                </list-item>
                <list-item>
                  <p>Dressings impregnated with an emollient such as petrolatum or topical antiseptic (e.g., Vaseline<sup>&#x000ae;</sup> gauze, Adaptic<sup>&#x000ae;</sup>, Xeroform<sup>&#x000ae;</sup>)</p>
                </list-item>
                <list-item>
                  <p>Nonstick products (e.g., Telfa<sup>&#x000ae;</sup>, N-terface<sup>&#x000ae;</sup>)</p>
                </list-item>
                <list-item>
                  <p>Silicone-based products without adhesive (e.g., Mepitel<sup>&#x000ae;</sup>, Mepilex<sup>&#x000ae;</sup>)</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>A secondary layer that provides stability for the primary layer and adds padding to allow more activity. Rolls of gauze (e.g., Kerlix<sup>&#x000ae;</sup>) are commonly used.</p>
            </list-item>
            <list-item>
              <p>A tertiary layer that usually has some elastic properties and ensures the integrity of the dressing (e.g., Coban<sup>&#x000ae;</sup> or elasticized tube gauze of varying diameters such as Band Net<sup>&#x000ae;</sup>)</p>
            </list-item>
          </list>
          <p><bold>Other.</bold> The most common secondary complication is infection. In addition to wound care, treatment of chronic infection of wounds is a challenge. Many affected individuals become infected with resistant bacteria, most often methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> (MRSA) and <italic toggle="yes">Pseudomonas aeruginosa</italic>. Both antibiotics and antiseptics need to be employed.</p>
          <p>Esophageal strictures and webs can be dilated repeatedly to improve swallowing [<xref ref-type="bibr" rid="ebj.REF.azizkhan.2007.801">Azizkhan et al 2007</xref>].</p>
          <p>A hoarse cry in an infant should alert to the possibility of airway obstruction with granulation tissue. Decisions about tracheostomy should involve the family and take into consideration the medical condition of the infant. Because of the poor prognosis and severe pain and discomfort experienced by these infants, a discussion with the family and hospital ethics committee often helps to determine the type of intervention and comfort care to provide [<xref ref-type="bibr" rid="ebj.REF.yan.2007.307">Yan et al 2007</xref>, <xref ref-type="bibr" rid="ebj.REF.ida.2012.657">Ida et al 2012</xref>].</p>
          <p>Gastroesophageal reflux disease, when present, should be treated as in the general population.</p>
          <p>Some children have delays or difficulty walking because of blistering and hyperkeratosis. Appropriate footwear and physical therapy are essential to preserve ambulation.</p>
          <p>Treatment of granulation tissue can be attempted with high-potency topical steroids, silver nitrate, electrocautery, or autologous skin grafts.</p>
          <p>Psychosocial support, including social services and psychological counseling, is essential [<xref ref-type="bibr" rid="ebj.REF.lucky.2007.809">Lucky et al 2007</xref>].</p>
          <p>Pain management becomes an important part of daily care [<xref ref-type="bibr" rid="ebj.REF.goldschneider.2010.273">Goldschneider &#x00026; Lucky 2010</xref>]. In those with difficult-to-control pain, referral to a pain management specialist can be considered.</p>
          <p>Dental care is necessary because of inherent enamel abnormalities [<xref ref-type="bibr" rid="ebj.REF.kirkham.2000.377">Kirkham et al 2000</xref>, <xref ref-type="bibr" rid="ebj.REF.kr_mer.2012.1">Kr&#x000e4;mer et al 2012</xref>].</p>
          <p>Urologic and renal problems may be serious in this population [<xref ref-type="bibr" rid="ebj.REF.kajbafzadeh.2010.1763">Kajbafzadeh et al 2010</xref>]. For those affected individuals who survive, referral to a urologist may be considered.</p>
        </sec>
        <sec id="ebj.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Fluid and electrolyte problems, which can be significant and even life-threatening in the neonatal period and in infants with widespread disease, require careful management.</p>
          <p>In infants and children with JEB with more severe involvement, failure to thrive may be a problem, requiring additional nutritional support including a feeding gastrostomy when necessary to assure adequate caloric intake [<xref ref-type="bibr" rid="ebj.REF.haynes.2006.1097">Haynes 2006</xref>].</p>
          <p>In children who survive the newborn period, nutritional deficiencies must also be addressed when they are identified:</p>
          <list list-type="bullet">
            <list-item>
              <p>Calcium and vitamin D replacement for osteopenia and osteoporosis</p>
            </list-item>
            <list-item>
              <p>Zinc supplementation for wound healing [<xref ref-type="bibr" rid="ebj.REF.mellerio.2007.795">Mellerio et al 2007</xref>]</p>
            </list-item>
            <list-item>
              <p>Treatment of iron-deficiency anemia (a chronic problem) with oral or intravenous iron infusions and red blood cell transfusions</p>
            </list-item>
          </list>
          <p>Wound infections should be treated with the appropriate antiseptic or antimicrobial medication.</p>
        </sec>
        <sec id="ebj.Surveillance">
          <title>Surveillance</title>
          <p>Screening for iron-deficiency anemia should be routine, with complete blood counts and measurement of serum iron concentration to provide iron supplementation when necessary.</p>
          <p>Screening for zinc deficiency by measuring serum zinc concentration should be routine to provide zinc supplementation when necessary to enhance wound healing.</p>
          <p>Screening with bone mineral density scanning may detect early osteopenia and/or osteoporosis. No guidelines have been established regarding the age at which this should be initiated.</p>
          <p>Screening for dilated cardiomyopathy can be accomplished with regular echocardiograms [<xref ref-type="bibr" rid="ebj.REF.laracorrales.2010.238">Lara-Corrales et al 2010</xref>].</p>
          <p>Because of the risk for squamous cell carcinoma, surveillance in the second decade of life for wounds that do not heal, have exuberant scar tissue, or otherwise look abnormal is essential. Frequent biopsies of suspicious lesions followed by local excision may be necessary.</p>
        </sec>
        <sec id="ebj.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Most persons with JEB cannot use ordinary medical tape or Band-Aids<sup>&#x000ae;</sup>. Silicone-based products provide a good substitute for tape.</p>
          <p>Poorly fitting or coarse-textured clothing and footwear should be avoided as they can cause trauma.</p>
          <p>Activities that, in general, traumatize the skin (e.g., hiking, mountain biking, contact sports) should be avoided; affected individuals who are determined to participate in such activities should be encouraged to find creative ways to protect their skin.</p>
        </sec>
        <sec id="ebj.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="ebj.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="ebj.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p><bold>Cesarean section</bold> may be recommended to reduce trauma to the skin of an affected fetus during delivery.</p>
        </sec>
        <sec id="ebj.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Several approaches to gene therapy for JEB, focused on retroviral modification of in vitro epidermal cells, have been proposed [<xref ref-type="bibr" rid="ebj.REF.robbins.2001.5193">Robbins et al 2001</xref>, <xref ref-type="bibr" rid="ebj.REF.ortizurda.2003.1099">Ortiz-Urda et al 2003</xref>]. One successful clinical trial has been conducted using transplantation of sheets of genetically modified epidermal stem cells in one affected individual with biallelic <italic toggle="yes">LAMB3</italic> pathogenic variants [<xref ref-type="bibr" rid="ebj.REF.mavilio.2006.1397">Mavilio et al 2006</xref>, <xref ref-type="bibr" rid="ebj.REF.di_nunzio.2008.1977">Di Nunzio et al 2008</xref>]. Animal models include intra-amniotic prenatal laminin 332 delivery in mouse [<xref ref-type="bibr" rid="ebj.REF.m_hle.2006.1665">M&#x000fc;hle et al 2006</xref>] and a spontaneous form of JEB in dog [<xref ref-type="bibr" rid="ebj.REF.capt.2005.530">Capt et al 2005</xref>, <xref ref-type="bibr" rid="ebj.REF.spirito.2006.769">Spirito et al 2006</xref>].</p>
          <p>Natural gene therapy is being investigated using autologous revertant cells cultured from patches of non-blistering skin [<xref ref-type="bibr" rid="ebj.REF.pasmooij.2012.1374">Pasmooij et al 2012</xref>].</p>
          <p>The knockout mouse model for all JEB-related genes should facilitate the development of these therapeutic approaches [<xref ref-type="bibr" rid="ebj.REF.jiang.2005.xi">Jiang &#x00026; Uitto 2005</xref>]. Animal models that have been used to study EB were reviewed in <xref ref-type="bibr" rid="ebj.REF.natsuga.2010.137">Natsuga et al [2010]</xref>.</p>
          <p>Induced pleuripotent stem cells (IPS) are being studied in several laboratories around the world to address the treatment of other types of EB [<xref ref-type="bibr" rid="ebj.REF.tolar.2013.562">Tolar et al 2013</xref>, <xref ref-type="bibr" rid="ebj.REF.osborn.2013.1151">Osborn et al 2013</xref>].</p>
          <p>Protein replacement therapy with LAMB3 has been studied in vitro [<xref ref-type="bibr" rid="ebj.REF.igoucheva.2008.1476">Igoucheva et al 2008</xref>] with promising results.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="ebj.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="ebj.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Junctional epidermolysis bullosa (JEB) is inherited in an autosomal recessive manner.</p>
          <p>There is no evidence to date that a single (i.e., heterozygous) pathogenic variant in <italic toggle="yes">LAMA3</italic>, <italic toggle="yes">LAMB3</italic>, <italic toggle="yes">LAMC2</italic>, or <italic toggle="yes">COL17A1</italic> results in JEB. However dental anomalies have been reported in individuals who have a single <italic toggle="yes">LAMB3</italic> or <italic toggle="yes">COL17A1</italic> variant [<xref ref-type="bibr" rid="ebj.REF.mcgrath.1996.781">McGrath et al 1996</xref>, <xref ref-type="bibr" rid="ebj.REF.almaani.2009.1094">Almaani et al 2009</xref>, <xref ref-type="bibr" rid="ebj.REF.poulter.2014.132">Poulter et al 2014</xref>].</p>
        </sec>
        <sec id="ebj.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are usually obligate heterozygotes and therefore each parent carries one mutated allele. Because germline mosaicism and uniparental isodisomy have been reported [<xref ref-type="bibr" rid="ebj.REF.pulkkinen.1997.611">Pulkkinen et al 1997</xref>, <xref ref-type="bibr" rid="ebj.REF.takizawa.2000b.307">Takizawa et al 2000b</xref>, <xref ref-type="bibr" rid="ebj.REF.cserhalmifriedman.2002.468">Cserhalmi-Friedman et al 2002</xref>, <xref ref-type="bibr" rid="ebj.REF.fassihi.2005.71">Fassihi et al 2005</xref>], carrier status of parents needs to be confirmed with molecular genetic testing.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic except in a few rare instances where carriers of a <italic toggle="yes">COL17A1</italic> or a <italic toggle="yes">LAMB3</italic> pathogenic variant have been reported to have dental enamel hypoplasia and/or pitting with resulting caries [<xref ref-type="bibr" rid="ebj.REF.nakamura.2006.333">Nakamura et al 2006</xref>, <xref ref-type="bibr" rid="ebj.REF.murrell.2007.1772">Murrell et al 2007</xref>, <xref ref-type="bibr" rid="ebj.REF.kim.2013.899">Kim et al 2013</xref>, <xref ref-type="bibr" rid="ebj.REF.poulter.2014.132">Poulter et al 2014</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual whose parents are both carriers has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic except in the case of <italic toggle="yes">COL17A1</italic> or <italic toggle="yes">LAMB3</italic> pathogenic variants where carriers may exhibit dental enamel hypoplasia and/or pitting and caries [<xref ref-type="bibr" rid="ebj.REF.nakamura.2006.333">Nakamura et al 2006</xref>, <xref ref-type="bibr" rid="ebj.REF.murrell.2007.1772">Murrell et al 2007</xref>, <xref ref-type="bibr" rid="ebj.REF.kim.2013.899">Kim et al 2013</xref>, <xref ref-type="bibr" rid="ebj.REF.poulter.2014.132">Poulter et al 2014</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with autosomal recessive JEB are obligate heterozygotes (carriers) for a pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's carrier parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="ebj.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible if the pathogenic variants in the family have been identified.</p>
        </sec>
        <sec id="ebj.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="ebj.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the <italic toggle="yes">LAMA3</italic>, <italic toggle="yes">LAMB3</italic>, <italic toggle="yes">LAMC2</italic>, or <italic toggle="yes">COL17A1</italic> pathogenic variants have been identified in an affected family member, prenatal diagnosis and preimplantation genetic diagnosis for a pregnancy at increased risk for JEB are possible options.</p>
          <p><bold>Fetoscopy.</bold> Electron microscopic evaluation of fetal skin biopsies obtained by fetoscopy is also diagnostic in JEB. Fetoscopy carries a greater risk to pregnancy than CVS or amniocentesis and is performed relatively late (18-20 weeks) in gestation. Prenatal diagnosis for JEB using fetoscopy is not currently available in the US, but may be available in Europe.</p>
        </sec>
      </sec>
      <sec id="ebj.Resources">
        <title>Resources</title>
      </sec>
      <sec id="ebj.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="ebj.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The proteins encoded by <italic toggle="yes">LAMA3</italic>, <italic toggle="yes">LAMB3</italic>, and <italic toggle="yes">LAMC2</italic> assemble into the laminin 332 heterotrimer (aka LAM5 [<xref ref-type="bibr" rid="ebj.REF.aumailley.2005.326">Aumailley et al 2005</xref>]). A pathogenic variant in these genes can lead to reduced resistance to minor trauma and the resulting mucocutaneous blistering that is the hallmark of junctional epidermolysis bullosa (JEB). The type of variant, the biochemical properties of the substituted amino acid, if present, and its location determine the severity of the blistering phenotype (see <xref ref-type="sec" rid="ebj.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>). Pathogenic nonsense variants predominate in the severe forms of JEB and result in the absence of one of the three proteins that assemble into laminin 332. Pathogenic missense variants in key positions of the protein subunits affect the ability of the laminin &#x003b1;3, &#x003b2;3, and &#x003b3;2 polypeptides to assemble into a trimeric molecule, its secondary structure, and its ability to form the intracellular anchoring fibrils of the lamina densa.</p>
          <p>Collagen XVII forms an integral part of the hemidesmosome and has an intracellular as well as extracellular component. There is evidence that it interacts with alpha-6 integrin within the hemidesmosome. The hemidesmosomes &#x02013; structures made up of several protein components including COLXVII, alpha-6 beta-4 integrin, BPAG1, and plectin &#x02013; anchor the epidermal cells to the underlying dermis. The type and position of variants in <italic toggle="yes">COL17A1</italic> determine whether some partially functional protein is made and also affect the level of the cleavage plane of the skin. In some cases, variants affecting the intracellular domain result in a cleavage plane within the lowest level of the basal keratinocytes usually associated with EBS [<xref ref-type="bibr" rid="ebj.REF.charlesworth.2003.1344">Charlesworth et al 2003</xref>].</p>
          <sec id="ebj.LAMA3">
            <title>
              <italic toggle="yes">LAMA3</italic>
            </title>
            <p><bold>Gene structure.</bold> All of <italic toggle="yes">LAMA3</italic> is encoded in 76 exons spanning 318 kb on chromosome 18q11.2. Transcript variants are produced by alternative splicing (see <bold>Normal gene product</bold>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="ebj" object-id="ebj.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> Nonsense, missense, splicing, and insertion/deletion variants have been reported [<xref ref-type="bibr" rid="ebj.REF.nakano.2002a.41">Nakano et al 2002a</xref>, <xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>]. Premature termination codon pathogenic variants on both alleles result in the severe (Herlitz) form of JEB in most instances. A few mildly affected individuals with JEB with premature termination codon variants have been reported [<xref ref-type="bibr" rid="ebj.REF.nakano.2002a.41">Nakano et al 2002a</xref>]. Amino acid substitutions and splicing variants may result in a milder phenotype [<xref ref-type="bibr" rid="ebj.REF.posteraro.1998.758">Posteraro et al 1998</xref>, <xref ref-type="bibr" rid="ebj.REF.nakano.2002a.41">Nakano et al 2002a</xref>]. The common hot spot variants are reportedly present in approximately 45% of H-JEB cases in the US (see <xref ref-type="sec" rid="ebj.Testing_Strategy">Testing Strategy</xref>). These pathogenic variants invariably result in premature termination codons and when found on both alleles result in H-JEB. Overlapping phenotypes may exist in which pathogenic variants in <italic toggle="yes">LAMA3</italic> result in skin fragility with eye and laryngeal involvement [<xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>, <xref ref-type="bibr" rid="ebj.REF.figueira.2007.163">Figueira et al 2007</xref>].</p>
            <table-wrap id="ebj.T.lama3_pathogenic_variants_discusse" position="anchor" orientation="portrait">
              <label>Table 2. </label>
              <caption>
                <p><italic toggle="yes">LAMA3</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ebj.T.lama3_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_ebj.T.lama3_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_h_ebj.T.lama3_pathogenic_variants_discusse_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ebj.T.lama3_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.151insG&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_ebj.T.lama3_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val51GlyfsTer3</td>
                    <td headers="hd_h_ebj.T.lama3_pathogenic_variants_discusse_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=34452234">AY327114.1</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;val=34452235">AAQ72569.1</ext-link></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.lama3_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1948A&#x0003e;T</td>
                    <td headers="hd_h_ebj.T.lama3_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg650Ter</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="ebj.TF.2.1">
                  <label>1. </label>
                  <p>See <xref ref-type="sec" rid="ebj.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</xref>.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> There are three isoforms <italic toggle="yes">(LAMA3</italic>a, <italic toggle="yes">LAMA3</italic>b1, and <italic toggle="yes">LAMA3</italic>b2) produced by alternative splicing. Of the two <italic toggle="yes">LAMA3</italic>b isoforms, <italic toggle="yes">LAMA3</italic>b1 encodes a longer protein of 3,333 amino acids in 75 exons (exons 1-38 and 40-76 of the gene); the shorter isoform <italic toggle="yes">LAMA3</italic>b2 encodes a protein of 3289 amino acids in 74 exons (exons 1-9, 11-38, and 40-76 of the gene) and differs from <italic toggle="yes">LAMA3</italic>b1 in that exon 10 is removed by alternative splicing. The shorter <italic toggle="yes">LAMA3</italic>a isoform of 1724 amino acids is encoded in 38 exons (exons 39-76 of <italic toggle="yes">LAMA3</italic>) and is unique in that exon 39 is expressed.</p>
            <p>The laminin A3 protein associates with laminin B3 and C2 proteins to form the laminin 332 heterotrimer that comprises the anchoring fibrils in the epidermis. The anchoring fibrils hold the layers of the basal lamina together and form associations with collagen VII on the dermal side and plectin and &#x003b1;6 &#x003b2;4 integrin in the hemidesmosomes on the epidermal side. This interaction allows the formation of the protein network of the epidermis, which results in a flexible and resilient barrier to resist trauma.</p>
            <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="ebj.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>. In all three genes (<italic toggle="yes">LAMB3</italic>, <italic toggle="yes">LAMC2</italic>, and <italic toggle="yes">LAMA3</italic>), amino acid substitutions, splicing variants, and in-frame deletions and insertions may result in the formation of some partially functional protein that results in a milder phenotype. Specific amino acid substitutions, such as replacement of cysteine residues, inhibit the formation of disulfide bonds, result in altered laminin 332 intra- and intermolecular associations, and may result in a more severe phenotype. Usually, on a skin biopsy studied with immunofluorescence, if synthesis of one of the proteins is disrupted, the staining for the other two proteins will also be affected.</p>
          </sec>
          <sec id="ebj.LAMB3">
            <title>
              <italic toggle="yes">LAMB3</italic>
            </title>
            <p><bold>Gene structure.</bold> The normal <italic toggle="yes">LAMB3</italic> cDNA has an open reading frame of 3516 nucleotides in 23 exons spanning 29 kb. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="ebj" object-id="ebj.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> Nonsense, missense, splicing, and insertion/deletion variants have been reported [<xref ref-type="bibr" rid="ebj.REF.nakano.2002b.510">Nakano et al 2002b</xref>, <xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>]. A few mildly affected persons with premature termination codon variants have been reported [<xref ref-type="bibr" rid="ebj.REF.pulkkinen.1998.935">Pulkkinen et al 1998</xref>, <xref ref-type="bibr" rid="ebj.REF.nakano.2002a.41">Nakano et al 2002a</xref>]. Amino acid substitutions and splicing variants may result in a milder phenotype [<xref ref-type="bibr" rid="ebj.REF.mellerio.1998.325">Mellerio et al 1998</xref>, <xref ref-type="bibr" rid="ebj.REF.posteraro.1998.758">Posteraro et al 1998</xref>, <xref ref-type="bibr" rid="ebj.REF.nakano.2002a.41">Nakano et al 2002a</xref>].</p>
            <table-wrap id="ebj.T.lamb3_pathogenic_variants_discusse" position="anchor" orientation="portrait">
              <label>Table 3. </label>
              <caption>
                <p><italic toggle="yes">LAMB3</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ebj.T.lamb3_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_ebj.T.lamb3_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_h_ebj.T.lamb3_pathogenic_variants_discusse_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ebj.T.lamb3_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.124C&#x0003e;T</td>
                    <td headers="hd_h_ebj.T.lamb3_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg42Ter</td>
                    <td headers="hd_h_ebj.T.lamb3_pathogenic_variants_discusse_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=62868214">NM_000228.2</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=62868215">NP_000219.2</ext-link></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.lamb3_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.727C&#x0003e;T</td>
                    <td headers="hd_h_ebj.T.lamb3_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln243Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.lamb3_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.957ins77</td>
                    <td headers="hd_h_ebj.T.lamb3_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu320Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ebj.T.lamb3_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1903C&#x0003e;T</td>
                    <td headers="hd_h_ebj.T.lamb3_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg635Ter</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The laminin B3 protein has 1,172 amino acids. It associates with laminin A3 and C2 proteins to form the laminin 332 heterotrimer that comprises the anchoring fibrils in the epidermis.</p>
            <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="ebj.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>. In all three genes (<italic toggle="yes">LAMB3</italic>, <italic toggle="yes">LAMC2</italic>, and <italic toggle="yes">LAMA3</italic>), amino acid substitutions, splicing variants, and in-frame deletions and insertions may result in the formation of some partially functional protein that results in a milder phenotype. Specific amino acid substitutions, such as replacement of cysteine residues, inhibit the formation of disulfide bonds, result in altered laminin 332 intra- and intermolecular associations, and may result in a more severe phenotype. Usually, on a skin biopsy studied with immunofluorescence, if synthesis of one of the proteins is disrupted, the staining for the other two proteins will also be affected. Reversion by <italic toggle="yes">LAMB3</italic> mosaicism to a normal phenotype has been described and has implications for treatment [<xref ref-type="bibr" rid="ebj.REF.pasmooij.2007.1240">Pasmooij et al 2007</xref>].</p>
          </sec>
          <sec id="ebj.LAMC2">
            <title>
              <italic toggle="yes">LAMC2</italic>
            </title>
            <p><bold>Gene structure.</bold> Two <italic toggle="yes">LAMC2</italic> transcript variants result from alternative splicing. The longer is expressed in the epidermis; the epidermal <italic toggle="yes">LAMC2</italic> cDNA has an open reading frame of 3573 nucleotides encoding 1191 amino acids in 23 exons spanning 55 kb. The shorter transcript variant terminates two codons past exon 22 and is expressed in the cerebral cortex, lung, and distal tubules of the kidney. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="ebj" object-id="ebj.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> Nonsense, missense, splicing, and insertion/deletion variants have been reported [<xref ref-type="bibr" rid="ebj.REF.castiglia.2001.731">Castiglia et al 2001</xref>, <xref ref-type="bibr" rid="ebj.REF.nakano.2002b.510">Nakano et al 2002b</xref>, <xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>]. Amino acid substitutions and splicing variants may result in a milder phenotype [<xref ref-type="bibr" rid="ebj.REF.posteraro.1998.758">Posteraro et al 1998</xref>, <xref ref-type="bibr" rid="ebj.REF.castiglia.2001.731">Castiglia et al 2001</xref>, <xref ref-type="bibr" rid="ebj.REF.nakano.2002a.41">Nakano et al 2002a</xref>].</p>
            <table-wrap id="ebj.T.lamc2_pathogenic_variants_discusse" position="anchor" orientation="portrait">
              <label>Table 4. </label>
              <caption>
                <p><italic toggle="yes">LAMC2</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ebj.T.lamc2_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_ebj.T.lamc2_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_h_ebj.T.lamc2_pathogenic_variants_discusse_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ebj.T.lamc2_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.283C&#x0003e;T</td>
                    <td headers="hd_h_ebj.T.lamc2_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg95Ter</td>
                    <td headers="hd_h_ebj.T.lamc2_pathogenic_variants_discusse_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;val=157419137">NM_005562.2</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;val=NP_005553.2">NP_005553.2</ext-link></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The laminin C2 protein associates with laminins A3 and C2 to form the laminin 332 heterotrimer that makes up the anchoring fibrils in the epidermis.</p>
            <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="ebj.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>. In all three genes (<italic toggle="yes">LAMB3</italic>, <italic toggle="yes">LAMC2</italic>, and <italic toggle="yes">LAMA3</italic>), amino acid substitutions, splicing variants, and in-frame deletions and insertions may result in the formation of some partially functional protein that results in a milder phenotype. Specific amino acid substitutions, such as replacement of cysteine residues, inhibit the formation of disulfide bonds, result in altered laminin 332 intra- and intermolecular associations, and may result in a more severe phenotype. Usually, on a skin biopsy studied with immunofluorescence, if synthesis of one of the proteins is disrupted, the staining for the other two proteins will also be affected.</p>
          </sec>
          <sec id="ebj.COL17A1">
            <title>
              <italic toggle="yes">COL17A1</italic>
            </title>
            <p><bold>Gene structure.</bold> The cDNA has an open reading frame of 5610 nucleotides encoding 1497 amino acids in 56 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="ebj" object-id="ebj.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign allelic variants.</bold> There is one alternatively spliced mRNA variant [<xref ref-type="bibr" rid="ebj.REF.ruzzi.2001.182">Ruzzi et al 2001</xref>].</p>
            <p><bold>Pathogenic allelic variants.</bold> Pathogenic variants in <italic toggle="yes">COL17A1</italic>, which encodes the collagen XVII protein, a component of the hemidesmosome, result in typically less severe forms of JEB (non-Herlitz) [<xref ref-type="bibr" rid="ebj.REF.gatalica.1997.352">Gatalica et al 1997</xref>, <xref ref-type="bibr" rid="ebj.REF.pulkkinen.1999.1114">Pulkkinen et al 1999</xref>, <xref ref-type="bibr" rid="ebj.REF.takizawa.2000a.312">Takizawa et al 2000a</xref>, <xref ref-type="bibr" rid="ebj.REF.van_leusden.2001.887">van Leusden et al 2001</xref>, <xref ref-type="bibr" rid="ebj.REF.pasmooij.2004b.125">Pasmooij et al 2004b</xref>], although a few cases of lethal JEB resulting from <italic toggle="yes">COL17A1</italic> pathogenic variants have been reported [<xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>, <xref ref-type="bibr" rid="ebj.REF.murrell.2007.1772">Murrell et al 2007</xref>]. All types of variants (including premature termination codon, nonsense, insertion/deletion, splice junction, and missense variants) distributed throughout the gene have been described. The type and location of the variants and the response of the cells to the variants determines the phenotype, which can range from mild to severe and in some cases lethal. Reversion to a normal phenotype has been described [<xref ref-type="bibr" rid="ebj.REF.pasmooij.2005.727">Pasmooij et al 2005</xref>].</p>
            <p><bold>Normal gene product.</bold> Collagen XVII (also known as BP180) is composed of intracellular and extracellular domains separated by a transmembrane domain that distinguishes collagen XVII from other collagen family members. The intracellular domain is localized within the basal keratinocyte; the ectodomain is localized outside the cell and serves as an association point with other components of the basement membrane zone. The carboxy-terminal half of collagen XVII, a stretch of 916 amino acids, consists of 15 collagen domains of variable length (15 to 242 amino acids) that are separated by short stretches of non-collagen sequences. The collagenous domains associate to form a homotrimeric triple helical segment of the molecule characteristic of all collagen family members.</p>
            <p><bold>Abnormal gene product.</bold> Premature termination codon pathogenic variants that result in a null allele cause skin fragility, dental abnormalities, and alopecia usually found in patients with NH-JEB. Other pathogenic variants may result in varying phenotypic severity. Although <italic toggle="yes">COL17A1</italic> variants do not usually result in lethality, several cases of a neonatal lethal phenotype were recently described [<xref ref-type="bibr" rid="ebj.REF.varki.2006.641">Varki et al 2006</xref>, <xref ref-type="bibr" rid="ebj.REF.murrell.2007.1772">Murrell et al 2007</xref>]. Pathogenic variants that affect the intracellular domain may result in a cleavage plane more consistent with EBS and be misleading in terms of diagnosis based on electron microscopy biopsy results. Pathogenic variants that affect the transmembrane domain may result in intracellular accumulation of collagen XVII protein. Although glycine substitutions in <italic toggle="yes">COL17A1</italic> have been described, no autosomal dominant variants resulting in skin fragility have been identified. Heterozygote carriers of a glycine substitution [<xref ref-type="bibr" rid="ebj.REF.nakamura.2006.333">Nakamura et al 2006</xref>] or other <italic toggle="yes">COL17A1</italic> variants [<xref ref-type="bibr" rid="ebj.REF.murrell.2007.1772">Murrell et al 2007</xref>] may exhibit dental enamel pitting and this characteristic may be diagnostic for <italic toggle="yes">COL17A1</italic> pathogenic variants in a family with an affected child [<xref ref-type="bibr" rid="ebj.REF.murrell.2007.1772">Murrell et al 2007</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="ebj.References">
        <title>References</title>
        <sec id="ebj.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="ebj.Literature_Cited.reflist0">
            <ref id="ebj.REF.almaani.2009.1094">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Almaani</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dopping-Hepenstal</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovell</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai-Cheong</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant junctional epidermolysis bullosa.</article-title>
                <source>Br J Dermatol.</source>
                <year>2009</year>
                <volume>160</volume>
                <fpage>1094</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19120338</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.antonlamprecht.2002">
              <mixed-citation publication-type="book">Anton-Lamprecht I, Gedde-Dahl T. Epidermolysis bullosa. In: Rimoin DL, Connor MJ, Pyeritz RE, Korf BR, Emery AEH, eds. <italic toggle="yes">Emery and Rimoin&#x02019;s Principles and Practice of Medical Genetics</italic>. 4 ed. London, UK: Churchill Livingstone Publishers; 2002:3810-97.</mixed-citation>
            </ref>
            <ref id="ebj.REF.aumailley.2005.326">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aumailley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deutzmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edgar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ekblom</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engvall</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hohenester</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleinman</surname>
                    <given-names>HK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marinkovich</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miner</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyazaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patarroyo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paulsson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quaranta</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanes</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sekiguchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorokin</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talts</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tryggvason</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Virtanen</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von der Mark</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wewer</surname>
                    <given-names>UM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yurchenco</surname>
                    <given-names>PD</given-names>
                  </name>
                </person-group>
                <article-title>A simplified laminin nomenclature.</article-title>
                <source>Matrix Biol.</source>
                <year>2005</year>
                <volume>24</volume>
                <fpage>326</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">15979864</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.azarian.2006.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Azarian</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dreux</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vuillard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haber</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guimiot</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal diagnosis of inherited epidermolysis bullosa in a patient with no family history: a case report and literature review.</article-title>
                <source>Prenat Diagn.</source>
                <year>2006</year>
                <volume>26</volume>
                <fpage>57</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16378325</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.azizkhan.2007.801">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Azizkhan</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denyer</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacigalupo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kantor</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passalacqua</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palisson</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                </person-group>
                <article-title>Surgical management of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile.</article-title>
                <source>Int J Dermatol.</source>
                <year>2007</year>
                <volume>46</volume>
                <fpage>801</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17651160</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.bolling.2010.1388">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bolling</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veenstra</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diercks</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curry</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <article-title>Lethal acantholytic epidermolysis bullosa due to a novel homozygous deletion in DSP: expanding the phenotype and implications for desmoplakin function in skin and heart.</article-title>
                <source>Br J Dermatol.</source>
                <year>2010</year>
                <volume>162</volume>
                <fpage>1388</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">20302578</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.bolling.2014.273">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bolling</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jongbloed</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boven</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diercks</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>Plectin mutations underlie epidermolysis bullosa simplex in 8% of patients.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2014</year>
                <volume>134</volume>
                <fpage>273</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23774525</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.capt.2005.530">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Capt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spirito</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guaguere</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spadafora</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortonne</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Inherited junctional epidermolysis bullosa in the German Pointer: establishment of a large animal model.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2005</year>
                <volume>124</volume>
                <fpage>530</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15737193</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.castiglia.2001.731">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Castiglia</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Posteraro</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spirito</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinola</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puddu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambruno</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Novel mutations in the LAMC2 gene in non-Herlitz junctional epidermolysis bullosa: effects on laminin-5 assembly, secretion, and deposition.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2001</year>
                <volume>117</volume>
                <fpage>731</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11564184</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.charlesworth.2003.1344">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Charlesworth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gagnoux-Palacios</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonduelle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortonne</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Raeve</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Identification of a lethal form of epidermolysis bullosa simplex associated with a homozygous genetic mutation in plectin.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2003</year>
                <volume>121</volume>
                <fpage>1344</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14675180</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.cohn.2010.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>HI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>DF</given-names>
                  </name>
                </person-group>
                <article-title>Laryngo-onycho-cutaneous syndrome.</article-title>
                <source>Dermatol Clin.</source>
                <year>2010</year>
                <volume>28</volume>
                <fpage>89</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">19945620</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.cserhalmifriedman.2002.468">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cserhalmi-Friedman</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anyane-Yeboa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiano</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>Paternal germline mosaicism in Herlitz junctional epidermolysis bullosa.</article-title>
                <source>Exp Dermatol.</source>
                <year>2002</year>
                <volume>11</volume>
                <fpage>468</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">12366701</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.cserhalmifriedman.1998.105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cserhalmi-Friedman</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgeson</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiano</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>Molecular basis of non-lethal junctional epidermolysis bullosa: identification of a 38 basepair insertion and a splice site mutation in exon 14 of the LAMB3 gene.</article-title>
                <source>Exp Dermatol.</source>
                <year>1998</year>
                <volume>7</volume>
                <fpage>105</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">9583749</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.denyer.2010.257">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Denyer</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <article-title>Wound management for children with epidermolysis bullosa.</article-title>
                <source>Dermatol Clin.</source>
                <year>2010</year>
                <volume>28</volume>
                <fpage>257</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">20447488</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.di_nunzio.2008.1977">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Nunzio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maruggi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Iorio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poletti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Rio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Luca</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larcher</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellegrini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mavilio</surname>
                    <given-names>F.</given-names>
                  </name>
                </person-group>
                <article-title>Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectors.</article-title>
                <source>Mol Ther.</source>
                <year>2008</year>
                <volume>16</volume>
                <fpage>1977</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">18813277</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.dolan.1993.395">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dolan</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>LT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sybert</surname>
                    <given-names>VP</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal detection of epidermolysis bullosa letalis with pyloric atresia in a fetus by abnormal ultrasound and elevated alpha-fetoprotein.</article-title>
                <source>Am J Med Genet.</source>
                <year>1993</year>
                <volume>47</volume>
                <fpage>395</fpage>
                <lpage>400</lpage>
                <pub-id pub-id-type="pmid">7510931</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.fassihi.2005.71">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fassihi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessagowit</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denyer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Complete paternal uniparental isodisomy of chromosome 1 resulting in Herlitz junctional epidermolysis bullosa.</article-title>
                <source>Clin Exp Dermatol.</source>
                <year>2005</year>
                <volume>30</volume>
                <fpage>71</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15663509</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.fewtrell.2006.959">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fewtrell</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allgrove</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordon</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brain</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <article-title>Bone mineralization in children with epidermolysis bullosa.</article-title>
                <source>Br J Dermatol.</source>
                <year>2006</year>
                <volume>154</volume>
                <fpage>959</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">16634901</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.figueira.2007.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Figueira</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crotty</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Challinor</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coroneo</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>DF</given-names>
                  </name>
                </person-group>
                <article-title>Granulation tissue in the eyelid margin and conjunctiva in junctional epidermolysis bullosa with features of laryngo-onycho-cutaneous syndrome.</article-title>
                <source>Clin Experiment Ophthalmol.</source>
                <year>2007</year>
                <volume>35</volume>
                <fpage>163</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17362460</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.fine.1999">
              <mixed-citation publication-type="book">Fine JD, Bauer EA, McGuire J Moshell A, eds. <italic toggle="yes">Epidermolysis Bullosa; Clinical Epidemiologic, and Laboratory Advances and the Findings of the National Epidermolysis Bullosa Registry</italic>. Baltimore, MD: Johns Hopkins University Press; 1999.</mixed-citation>
            </ref>
            <ref id="ebj.REF.fine.2000.1051">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briggaman</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heagerty</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hintner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuire</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moshell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2000</year>
                <volume>42</volume>
                <fpage>1051</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">10827412</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.fine.2008.677">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchindran</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>The risk of cardiomyopathy in inherited epidermolysis bullosa.</article-title>
                <source>Br J Dermatol.</source>
                <year>2008</year>
                <volume>159</volume>
                <fpage>677</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">18616785</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.fine.2009.203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchindran</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2009</year>
                <volume>60</volume>
                <fpage>203</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">19026465</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.fine.2004.651">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cash</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeLeoz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devries</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchindran</surname>
                    <given-names>C</given-names>
                  </name>
                  <collab>National Epidermolysis Bullosa Registry</collab>
                </person-group>
                <article-title>Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry.</article-title>
                <source>Am J Kidney Dis.</source>
                <year>2004</year>
                <volume>44</volume>
                <fpage>651</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">15384016</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.gatalica.1997.352">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gatalica</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuokkanen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryyn&#x000e4;nen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Cloning of the human type XVII collagen gene (COL17A1), and detection of novel mutations in generalized atrophic benign epidermolysis bullosa.</article-title>
                <source>Am J Hum Genet.</source>
                <year>1997</year>
                <volume>60</volume>
                <fpage>352</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">9012408</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.goldschneider.2010.273">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldschneider</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                </person-group>
                <article-title>Pain management in epidermolysis bullosa.</article-title>
                <source>Dermatol Clin.</source>
                <year>2010</year>
                <volume>28</volume>
                <fpage>273</fpage>
                <lpage>82</lpage>
                <comment>ix.</comment>
                <pub-id pub-id-type="pmid">20447492</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.haynes.2006.1097">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haynes</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <article-title>Nutritional support for children with epidermolysis bullosa.</article-title>
                <source>Br J Nurs.</source>
                <year>2006</year>
                <volume>15</volume>
                <fpage>1097</fpage>
                <lpage>101</lpage>
                <pub-id pub-id-type="pmid">17170656</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.hobbs.2010.2680">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hobbs</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Zwaag</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolling</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jongbloed</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Getsios</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paller</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <article-title>Insights from a desmoplakin mutation identified in lethal acantholytic epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2010</year>
                <volume>130</volume>
                <fpage>2680</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">20613772</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.huber.2002.185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huber</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Floeth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borradori</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000e4;cke</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rugg</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frenk</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hohl</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Deletion of the cytoplasmatic domain of BP180/collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2002</year>
                <volume>118</volume>
                <fpage>185</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">11851893</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.ida.2012.657">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ida</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livshitz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azizkhan</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elluru</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <article-title>Upper airway complications of junctional epidermolysis bullosa.</article-title>
                <source>J Pediatr.</source>
                <year>2012</year>
                <volume>160</volume>
                <fpage>657</fpage>
                <lpage>61.e1</lpage>
                <pub-id pub-id-type="pmid">22050875</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.igoucheva.2008.1476">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Igoucheva</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexeev</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Protein therapeutics for junctional epidermolysis bullosa: incorporation of recombinant beta3 chain into laminin 332 in beta3-/- keratinocytes in vitro.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2008</year>
                <volume>128</volume>
                <fpage>1476</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">18079746</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.inoue.2000.1061">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owaribe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>A homozygous missense mutation in the cytoplasmic tail of beta4 integrin, G931D, that disrupts hemidesmosome assembly and underlies Non-Herlitz junctional epidermolysis bullosa without pyloric atresia?</article-title>
                <source>J Invest Dermatol.</source>
                <year>2000</year>
                <volume>114</volume>
                <fpage>1061</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10792571</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.intong.2012.70">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Intong</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>DF</given-names>
                  </name>
                </person-group>
                <article-title>Inherited epidermolysis bullosa: new diagnostic criteria and classification.</article-title>
                <source>Clin Dermatol.</source>
                <year>2012</year>
                <volume>30</volume>
                <fpage>70</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22137229</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.irvine.2003.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Irvine</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WH</given-names>
                  </name>
                </person-group>
                <article-title>The molecular genetics of the genodermatoses: progress to date and future directions.</article-title>
                <source>Br J Dermatol.</source>
                <year>2003</year>
                <volume>148</volume>
                <fpage>1</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">12534588</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.jiang.2005.xi">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>QJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Animal models of epidermolysis bullosa--targets for gene therapy.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2005</year>
                <volume>124</volume>
                <fpage>xi</fpage>
                <lpage>xiii</lpage>
                <pub-id pub-id-type="pmid">15812910</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.jonkman.2002.1275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijenhuis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kloosterhuis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steege</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Deletion of a cytoplasmic domain of integrin beta4 causes epidermolysis bullosa simplex.</article-title>
                <source>J Invest Dermatol</source>
                <volume>119</volume>
                <fpage>1275</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">12485428</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.jonkman.2005.653">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasmooij</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasmans</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Berg</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ter Horst</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <article-title>Loss of desmoplakin tail causes lethal acantholytic epidermolysis bullosa.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2005</year>
                <volume>77</volume>
                <fpage>653</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">16175511</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.kajbafzadeh.2010.1763">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kajbafzadeh</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elmi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazaheri</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talab</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jan</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Genitourinary involvement in epidermolysis bullosa: clinical presentations and therapeutic challenges.</article-title>
                <source>BJU Int.</source>
                <year>2010</year>
                <volume>106</volume>
                <fpage>1763</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20477826</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.kambham.2000.190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kambham</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanji</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seigle</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markowitz</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Agati</surname>
                    <given-names>VD</given-names>
                  </name>
                </person-group>
                <article-title>Congenital focal segmental glomerulosclerosis associated with beta4 integrin mutation and epidermolysis bullosa.</article-title>
                <source>Am J Kidney Dis.</source>
                <year>2000</year>
                <volume>36</volume>
                <fpage>190</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10873890</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.kellymancuso.2014.159">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kelly-Mancuso</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kopelan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azizkhan</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                </person-group>
                <article-title>Junctional epidermolysis bullosa incidence and survival: 5-year experience of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA) Nurse Educator.</article-title>
                <source>Pediatr Dermatol.</source>
                <year>2014</year>
                <volume>31</volume>
                <fpage>159</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">23721227</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.kim.2013.899">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seymen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yildirim</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuna</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gencay</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kyun</surname>
                    <given-names>HK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simmer</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <article-title>LAMB3 mutations causing autosomal dominant amelogenesis imperfecta.</article-title>
                <source>J Dent Res.</source>
                <year>2013</year>
                <volume>92</volume>
                <fpage>899</fpage>
                <lpage>904</lpage>
                <pub-id pub-id-type="pmid">23958762</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.kirkham.2000.377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kirkham</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strafford</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shore</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonass</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brookes</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <article-title>The chemical composition of tooth enamel in junctional epidermolysis bullosa.</article-title>
                <source>Arch Oral Biol.</source>
                <year>2000</year>
                <volume>45</volume>
                <fpage>377</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">10739859</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.kossharnes.2002.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koss-Harnes</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f8;yheim</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anton-Lamprecht</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gjesti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000f8;rgensen</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jahnsen</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olaisen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiche</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gedde-Dahl</surname>
                    <given-names>T</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2002</year>
                <volume>118</volume>
                <fpage>87</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">11851880</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.kossharnes.2004.124">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koss-Harnes</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f8;yheim</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Groot</surname>
                    <given-names>WP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Weerdt</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikolic</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiche</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gedde-Dahl</surname>
                    <given-names>T</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>Life-long course and molecular characterization of the original Dutch family with epidermolysis bullosa simplex with muscular dystrophy due to a homozygous novel plectin point mutation.</article-title>
                <source>Acta Derm Venereol.</source>
                <year>2004</year>
                <volume>84</volume>
                <fpage>124</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15206692</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.kr_mer.2012.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kr&#x000e4;mer</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serrano</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zillmann</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e1;lvez</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araya</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanine</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrasco-Labra</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliva</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brignardello-Petersen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villanueva</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>DEBRA International. Oral health care for patients with epidermolysis bullosa--best clinical practice guidelines.</article-title>
                <source>Int J Paediatr Dent.</source>
                <year>2012</year>
                <volume>22</volume>
                <supplement>Suppl 1</supplement>
                <fpage>1</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">22937908</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.kr_mer.2010.303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kr&#x000e4;mer</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Oral care and dental management for patients with epidermolysis bullosa.</article-title>
                <source>Dermatol Clin.</source>
                <year>2010</year>
                <volume>28</volume>
                <fpage>303</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20447495</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.kunz.2000.376">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kunz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamm</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeschke</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Br&#x000f6;cker</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiche</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zillikens</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Mutation reports: epidermolysis bullosa simplex associated with severe mucous membrane involvement and novel mutations in the plectin gene.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2000</year>
                <volume>114</volume>
                <fpage>376</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">10652001</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.laimer.2010.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laimer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanschuetzer</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diem</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <article-title>Herlitz junctional epidermolysis bullosa.</article-title>
                <source>Dermatol Clin.</source>
                <year>2010</year>
                <volume>28</volume>
                <fpage>55</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">19945616</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.laracorrales.2010.238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lara-Corrales</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azizkhan</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agero</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kantor</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pope</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Dilated cardiomyopathy in epidermolysis bullosa: a retrospective, multicenter study.</article-title>
                <source>Pediatr Dermatol.</source>
                <year>2010</year>
                <volume>27</volume>
                <fpage>238</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">20609141</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.lucky.2007.809">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pillay</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paskel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palisson</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Psychosocial aspects of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile.</article-title>
                <source>Int J Dermatol.</source>
                <year>2007</year>
                <volume>46</volume>
                <fpage>809</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">17651161</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.mavilio.2006.1397">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mavilio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellegrini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Nunzio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Iorio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Recchia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maruggi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Provasi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capurro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magnoni</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giannetti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Luca</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.</article-title>
                <source>Nat Med.</source>
                <year>2006</year>
                <volume>12</volume>
                <fpage>1397</fpage>
                <lpage>402</lpage>
                <pub-id pub-id-type="pmid">17115047</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.mcgrath.1999.314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salas-Alanis</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swensson</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMillan</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <article-title>Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.</article-title>
                <source>J Invest Dermatol.</source>
                <year>1999</year>
                <volume>113</volume>
                <fpage>314</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">10469327</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.mcgrath.2010.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <article-title>Ectodermal dysplasia-skin fragility syndrome.</article-title>
                <source>Dermatol Clin.</source>
                <year>2010</year>
                <volume>28</volume>
                <fpage>125</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19945625</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.mcgrath.1996.781">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivirikko</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciatti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiano</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>A recurrent homozygous nonsense mutation within the LAMA3 gene as a cause of Herlitz junctional epidermolysis bullosa in patients of Pakistani ancestry: evidence for a founder effect.</article-title>
                <source>J Invest Dermatol.</source>
                <year>1996</year>
                <volume>106</volume>
                <fpage>781</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">8618022</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.mclean.2003.2395">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irvine</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamill</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whittock</surname>
                    <given-names>NV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman-Campbell</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dopping-Hepenstal</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jamil</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shabbir</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haroon</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khurshid</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Page</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darling</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Steensel</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munro</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2003</year>
                <volume>12</volume>
                <fpage>2395</fpage>
                <lpage>409</lpage>
                <pub-id pub-id-type="pmid">12915477</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.mellerio.1998.325">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lake</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>E210K mutation in the gene encoding the beta3 chain of laminin-5 (LAMB3) is predictive of a phenotype of generalized atrophic benign epidermolysis bullosa.</article-title>
                <source>Br J Dermatol.</source>
                <year>1998</year>
                <volume>139</volume>
                <fpage>325</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">9767254</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.mellerio.2007.795">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denyer</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pillay</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palisson</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Medical management of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile.</article-title>
                <source>Int J Dermatol.</source>
                <year>2007</year>
                <volume>46</volume>
                <fpage>795</fpage>
                <lpage>800</lpage>
                <pub-id pub-id-type="pmid">17651159</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.micheloni.2004.796">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Micheloni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Luca</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambruno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Alessio</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Intracellular degradation of beta4 integrin in lethal junctional epidermolysis bullosa with pyloric atresia.</article-title>
                <source>Br J Dermatol.</source>
                <year>2004</year>
                <volume>151</volume>
                <fpage>796</fpage>
                <lpage>802</lpage>
                <pub-id pub-id-type="pmid">15491419</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.m_hle.2006.1665">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;hle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pacho</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waddington</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease.</article-title>
                <source>Gene Ther.</source>
                <year>2006</year>
                <volume>13</volume>
                <fpage>1665</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">16871230</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.murrell.2007.1772">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasmooij</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marr</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klingberg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadowski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Widmer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>Retrospective diagnosis of fatal BP180-deficient non-Herlitz junctional epidermolysis bullosa suggested by immunofluorescence (IF) antigen-mapping of parental carriers bearing enamel defects.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2007</year>
                <volume>127</volume>
                <fpage>1772</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17344927</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.nakamura.2006.333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ariga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakiyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomizawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H.</given-names>
                  </name>
                </person-group>
                <article-title>Analysis of the COL17A1 in non-Herlitz junctional epidermolysis bullosa and amelogenesis imperfecta.</article-title>
                <source>Int J Mol Med.</source>
                <year>2006</year>
                <volume>18</volume>
                <fpage>333</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16820943</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.nakamura.2005.28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMillan</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kono</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paku</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogiso</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Epidermolysis bullosa simplex associated with pyloric atresia is a novel clinical subtype caused by mutations in the plectin gene (PLEC1).</article-title>
                <source>J Mol Diagn.</source>
                <year>2005</year>
                <volume>7</volume>
                <fpage>28</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">15681471</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.nakano.2002a.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chao</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes.</article-title>
                <source>Hum Genet.</source>
                <year>2002a</year>
                <volume>110</volume>
                <fpage>41</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">11810295</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.nakano.2002b.510">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lestringant</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paperna</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gershoni</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frossard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanaan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sprecher</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Junctional epidermolysis bullosa in the Middle East: clinical and genetic studies in a series of consanguineous families.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2002b</year>
                <volume>46</volume>
                <fpage>510</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11907499</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.nakano.2000.493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Herlitz junctional epidermolysis bullosa: novel and recurrent mutations in the LAMB3 gene and the population carrier frequency.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2000</year>
                <volume>115</volume>
                <fpage>493</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11023379</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.natsuga.2010.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Natsuga</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinkuma</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishie</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Animal models of epidermolysis bullosa.</article-title>
                <source>Dermatol Clin.</source>
                <year>2010</year>
                <volume>28</volume>
                <fpage>137</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">19945627</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.ortizurda.2003.1099">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ortiz-Urda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yant</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kay</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khavari</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer.</article-title>
                <source>Gene Ther.</source>
                <year>2003</year>
                <volume>10</volume>
                <fpage>1099</fpage>
                <lpage>104</lpage>
                <pub-id pub-id-type="pmid">12808440</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.osborn.2013.1151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Osborn</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Starker</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McElroy</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webber</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riddle</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeFeo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabriel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Kalle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlson</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maeder</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joung</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voytas</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazar</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolar</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>TALEN-based gene correction for epidermolysis bullosa.</article-title>
                <source>Mol Ther.</source>
                <year>2013</year>
                <volume>21</volume>
                <fpage>1151</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23546300</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pasmooij.2012.1374">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasmooij</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijenhuis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brander</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2012</year>
                <volume>132</volume>
                <fpage>1374</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">22318390</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pasmooij.2007.1240">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasmooij</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolling</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3.</article-title>
                <source>J Clin Invest.</source>
                <year>2007</year>
                <volume>117</volume>
                <fpage>1240</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17476356</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pasmooij.2005.727">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasmooij</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deviaene</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijenhuis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2005</year>
                <volume>77</volume>
                <fpage>727</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">16252234</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pasmooij.2004a.669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasmooij</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Steege</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smitt</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijenhuis</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuiderveen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen.</article-title>
                <source>Br J Dermatol.</source>
                <year>2004a</year>
                <volume>151</volume>
                <fpage>669</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">15377356</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pasmooij.2004b.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasmooij</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Zalen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijenhuis</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kloosterhuis</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuiderveen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <article-title>A very mild form of non-Herlitz junctional epidermolysis bullosa: BP180 rescue by outsplicing of mutated exon 30 coding for the COL15 domain.</article-title>
                <source>Exp Dermatol.</source>
                <year>2004b</year>
                <volume>13</volume>
                <fpage>125</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15009107</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pfendner.2005.241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Progress in epidermolysis bullosa: the phenotypic spectrum of plectin mutations.</article-title>
                <source>Exp Dermatol.</source>
                <year>2005</year>
                <volume>14</volume>
                <fpage>241</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15810881</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pfendner.2001.483">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <article-title>Epidermolysis bullosa carrier frequencies in the US population.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2001</year>
                <volume>116</volume>
                <fpage>483</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11231335</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pfendner.2005.111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Plectin gene mutations can cause epidermolysis bullosa with pyloric atresia.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2005</year>
                <volume>124</volume>
                <fpage>111</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15654962</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pfendner.2007.781">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conget</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palisson</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                </person-group>
                <article-title>Basic science of epidermolysis bullosa and diagnostic and molecular characterization: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile.</article-title>
                <source>Int J Dermatol.</source>
                <year>2007</year>
                <volume>46</volume>
                <fpage>781</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">17651158</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pope.2012.904">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pope</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lara-Corrales</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schultz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrell</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutts</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sibbald</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>A consensus approach to wound care in epidermolysis bullosa.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2012</year>
                <volume>67</volume>
                <fpage>904</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">22387035</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.posteraro.2004.639">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Posteraro</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Luca</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El Hachem</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gobello</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambruno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castiglia</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2004</year>
                <volume>123</volume>
                <fpage>639</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">15373767</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.posteraro.1998.758">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Posteraro</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorvillo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gagnoux-Palacios</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paradisi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castiglia</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambruno</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Compound heterozygosity for an out-of-frame deletion and a splice site mutation in the LAMB3 gene causes nonlethal junctional epidermolysis bullosa.</article-title>
                <source>Biochem Biophys Res Commun.</source>
                <year>1998</year>
                <volume>243</volume>
                <fpage>758</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">9501007</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.poulter.2014.132">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Poulter</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Sayed</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shore</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkham</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mighell</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <article-title>Whole-exome sequencing, without prior linkage, identifies a mutation in LAMB3 as a cause of dominant hypoplastic amelogenesis imperfecta.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2014</year>
                <volume>22</volume>
                <fpage>132</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">23632796</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pulkkinen.1998.935">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>August</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Compound heterozygosity for missense (L156P) and nonsense (R554X) mutations in the beta4 integrin gene (ITGB4) underlies mild, nonlethal phenotype of epidermolysis bullosa with pyloric atresia.</article-title>
                <source>Am J Pathol.</source>
                <year>1998</year>
                <volume>152</volume>
                <fpage>935</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">9546354</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pulkkinen.1997.611">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bullrich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czarnecki</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Maternal uniparental disomy of chromosome 1 with reduction to homozygosity of the LAMB3 locus in a patient with Herlitz junctional epidermolysis bullosa.</article-title>
                <source>Am J Hum Genet.</source>
                <year>1997</year>
                <volume>61</volume>
                <fpage>611</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9326326</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pulkkinen.1999.1114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marinkovich</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herron</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol.</source>
                <year>1999</year>
                <volume>113</volume>
                <fpage>1114</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10636730</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pulkkinen.1995.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiano</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Detection of sequence variants in the gene encoding the beta 3 chain of laminin 5 (LAMB3).</article-title>
                <source>Hum Mutat.</source>
                <year>1995</year>
                <volume>6</volume>
                <fpage>77</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">7550237</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.pulkkinen.1999.29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Mutation analysis and molecular genetics of epidermolysis bullosa.</article-title>
                <source>Matrix Biol.</source>
                <year>1999</year>
                <volume>18</volume>
                <fpage>29</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">10367729</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.puvabanditsin.1997.359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Puvabanditsin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrow</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samransamraujkit</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>WC</given-names>
                  </name>
                </person-group>
                <article-title>Epidermolysis bullosa associated with congenital localized absence of skin, fetal abdominal mass, and pyloric atresia.</article-title>
                <source>Pediatr Dermatol.</source>
                <year>1997</year>
                <volume>14</volume>
                <fpage>359</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">9336805</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.robbins.2001.5193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robbins</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodnough</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tian</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khavari</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2001</year>
                <volume>98</volume>
                <fpage>5193</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11296269</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.ruzzi.2001.182">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ruzzi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Posteraro</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzanti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Didona</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owaribe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambruno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castiglia</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Alessio</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>A homozygous nonsense mutation in type XVII collagen gene (COL17A1) uncovers an alternatively spliced mRNA accounting for an unusually mild form of non-Herlitz junctional epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2001</year>
                <volume>116</volume>
                <fpage>182</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11168815</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.schara.2004.218">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>T&#x000fc;cke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;sslein</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zillikens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiche</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schr&#x000f6;der</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Severe mucous membrane involvement in epidermolysis bullosa simplex with muscular dystrophy due to a novel plectin gene mutation.</article-title>
                <source>Eur J Pediatr.</source>
                <year>2004</year>
                <volume>163</volume>
                <fpage>218</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">14963703</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.shinkuma.2011.412">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shinkuma</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMillan</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Ultrastructure and molecular pathogenesis of epidermolysis bullosa.</article-title>
                <source>Clin Dermatol.</source>
                <year>2011</year>
                <volume>29</volume>
                <fpage>412</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21679868</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.smith.1996.450">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leigh</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMillan</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rugg</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelsell</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bryant</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spurr</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geddes</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirtschig</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milana</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Bono</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owaribe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiche</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>EB</given-names>
                  </name>
                </person-group>
                <article-title>Plectin deficiency results in muscular dystrophy with epidermolysis bullosa.</article-title>
                <source>Nat Genet.</source>
                <year>1996</year>
                <volume>13</volume>
                <fpage>450</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8696340</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.spirito.2006.769">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spirito</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Rio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larcher</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guaguere</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danos</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Sustained phenotypic reversion of junctional epidermolysis bullosa dog keratinocytes: Establishment of an immunocompetent animal model for cutaneous gene therapy.</article-title>
                <source>Biochem Biophys Res Commun.</source>
                <year>2006</year>
                <volume>339</volume>
                <fpage>769</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">16316622</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.stellingsma.2011.405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stellingsma</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dijkstra</surname>
                    <given-names>PU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dijkstra</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duipmans</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dekker</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Restrictions in oral functions caused by oral manifestations of epidermolysis bullosa.</article-title>
                <source>Eur J Dermatol.</source>
                <year>2011</year>
                <volume>21</volume>
                <fpage>405</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21609900</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.takizawa.2000a.312">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takizawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiraoka</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiko</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasuraoka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aiso</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishikawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Compound heterozygosity for a point mutation and a deletion located at splice acceptor sites in the LAMB3 gene leads to generalized atrophic benign epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2000a</year>
                <volume>115</volume>
                <fpage>312</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10951252</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.takizawa.2000b.307">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takizawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chao</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakajima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Mutation report: complete paternal uniparental isodisomy of chromosome 1: a novel mechanism for Herlitz junctional epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2000b</year>
                <volume>115</volume>
                <fpage>307</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">10951251</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.tolar.2013.562">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tolar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riddle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McElroy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osborn</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marinkovich</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazar</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <article-title>Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2013</year>
                <volume>133</volume>
                <fpage>562</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22931927</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.uitto.2005.33">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Progress in epidermolysis bullosa: from eponyms to molecular genetic classification.</article-title>
                <source>Clin Dermatol.</source>
                <year>2005</year>
                <volume>23</volume>
                <fpage>33</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">15708287</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.van_leusden.2001.887">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Leusden</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gedde-Dahl</surname>
                    <given-names>T</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Sonnenberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>Truncated typeXVII collagen expression in a patient with non-herlitz junctional epidermolysis bullosa caused by a homozygous splice-site mutation.</article-title>
                <source>Lab Invest.</source>
                <year>2001</year>
                <volume>81</volume>
                <fpage>887</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">11406649</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.varki.2006.641">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Varki</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadowski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants.</article-title>
                <source>J Med Genet.</source>
                <year>2006</year>
                <volume>43</volume>
                <fpage>641</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">16473856</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.varki.2007.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Varki</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadowski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E.</given-names>
                  </name>
                </person-group>
                <article-title>Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes.</article-title>
                <source>J Med Genet.</source>
                <year>2007</year>
                <volume>44</volume>
                <fpage>181</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">16971478</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.wallerstein.2000.286">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wallerstein</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genieser</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Epidermolysis bullosa, pyloric atresia, and obstructive uropathy: a report of two case reports with molecular correlation and clinical management.</article-title>
                <source>Pediatr Dermatol.</source>
                <year>2000</year>
                <volume>17</volume>
                <fpage>286</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10990577</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.yan.2007.307">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paris</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahluwalia</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <article-title>Treatment decision-making for patients with the Herlitz subtype of junctional epidermolysis bullosa.</article-title>
                <source>J Perinatol.</source>
                <year>2007</year>
                <volume>27</volume>
                <fpage>307</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">17363907</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.yuen.2013.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yuen</surname>
                    <given-names>WY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizinga</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>Punch grafting of chronic ulcers in patients with laminin-332-deficient, non-Herlitz junctional epidermolysis bullosa.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2013</year>
                <volume>68</volume>
                <fpage>93</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22633040</pub-id>
              </element-citation>
            </ref>
            <ref id="ebj.REF.yuen.2011.780">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yuen</surname>
                    <given-names>WY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2011</year>
                <volume>65</volume>
                <fpage>780</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21624701</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="ebj.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="ebj.Suggested_Reading.reflist0">
            <ref id="ebj.REF.van_coster">
              <mixed-citation publication-type="book">Van Coster R, Pulkkinen L. Epidermolysis bullosa: the disease of the cutaneous basement membrane zone. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID</italic>). New York, NY: McGraw-Hill. Chap 222. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com">online</ext-link>.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="ebj.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="ebj.Author_Notes">
          <title>Author Notes</title>
          <p>Web: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.genedx.com/">www.genedx.com</ext-link></p>
          <p>Web: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cincinnatichildrens.org/eb-center">www.cincinnatichildrens.org/eb-center</ext-link></p>
        </sec>
        <sec id="ebj.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>2 January 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>22 February 2008 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>10 May 2007 (egp) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="ebj.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Herlitz JEB a. Extensive widespread blistering and granulation tissue on ear b. Hand of a child showing aplasia cutis congenital c. Foot of an affected child d. Exuberant perioral granulation tissue and tracheostomy in a child</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ebj-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="ebj.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Non-Herlitz JEB e. Minor nail dystrophy in an older child f. Multiple blisters on the hands of an active toddler g. Non-scarring superficial axillary erosions</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ebj-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
